rfhg_109305.1

Basic information about the TSS

---

TSS ID: rfhg_109305.1 Species: human Chr: chr8		Start: 100951708 End: 100951730 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4126683,EH38E2652395)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000518736.5:113 GeneID: 7534 HGNC/MGI_ID: HGNC:12855 UniProt_ID: Nearer transcript ids and distances: ENST00000395953.6:114 ENST00000480304.5:-239 BC073141:-245 BC101483:-247 BC111951:-247 ENST00000395956.7:259 BC051814:259 BC063824:-264 AK315867:-279 AK307506:-287 ENST00000521309.5:-289 AK294647:-289 ENST00000395958.6:-290 NM_145690.3:-290 BC013265:-290 BC083508:-292 BC003623:-292 BC072426:-294 BC108281:-302 EU794583:-313 GQ472215:-313 BC068456:-313 U28964:-313 BC099904:-314 EU794582:379 NM_001135701.2:396 NM_001135700.2:396 ENST00000419477.6:432 view more...

Gene_name: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta Gene_symbol: YWHAZ Gene_synonyms: 14-3-3-zeta KCIP-1 Gene_source: HGNC:12855

TATA-Box annotation

---

Distance to TSS:	301
Nearest PromoterID:	NM_145690
Entrez ID:	7534
Nearest Unigene:	Hs.492407
Nearest Refseq:	NM_003406
Nearest Ensembl:	ENSG00000164924
Gene Name:	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
Gene Alias:	14-3-3-zeta|HEL-S-3|HEL-S-93|HEL4|KCIP-1|POPCHAS|YWHAD
Gene Type:	protein-coding
CpG%:	0.136364
GC%:	0.652174
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YWHAZ p2@YWHAZ p3@YWHAZ p4@YWHAZ p5@YWHAZ p6@YWHAZ p7@YWHAZ p8@YWHAZ p9@YWHAZ p10@YWHAZ
Sample		p1@YWHAZ	p2@YWHAZ	p3@YWHAZ	p4@YWHAZ	p5@YWHAZ	p6@YWHAZ	p7@YWHAZ	p8@YWHAZ	p9@YWHAZ	p10@YWHAZ
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	74.80	75.19	23.18	11.88	12.27	8.38	3.31	0.78	10.91	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	71.01	66.56	24.89	11.13	11.33	5.87	1.62	1.01	12.14	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	79.09	68.67	24.11	15.43	12.92	5.21	2.51	0.96	11.00	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	57.59	63.41	16.63	11.23	9.56	4.37	1.46	0.83	11.23	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	69.74	68.84	22.50	9.00	7.20	5.17	1.35	0.45	10.12	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	69.19	73.07	20.16	12.02	12.79	3.49	2.91	0.78	10.08	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	89.33	71.25	32.25	19.83	15.69	6.32	3.92	1.09	6.10	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	59.83	56.92	23.50	13.32	16.47	5.81	1.94	0.73	6.78	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	54.71	42.96	20.73	14.75	11.54	6.84	1.71	0.64	6.63	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	23.19	24.92	8.11	14.49	5.22	3.48	0.58	1.16	4.64	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	24.25	29.10	7.28	11.32	8.89	3.64	3.23	0.00	3.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	24.39	33.74	7.32	13.01	4.88	2.03	1.63	1.63	3.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	84.46	37.56	33.69	13.06	18.70	6.61	6.45	0.64	27.24	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	91.11	48.11	35.03	16.09	21.35	9.32	7.52	0.75	14.13	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	81.45	36.88	28.76	13.61	16.69	7.03	4.83	0.44	23.27	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	70.17	39.23	29.42	15.09	17.35	9.05	4.53	0.25	20.12	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	72.29	40.41	31.01	12.89	19.22	9.61	5.02	1.09	16.60	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	76.35	38.81	25.73	11.39	18.98	5.06	6.33	0.42	14.34	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	52.78	47.98	27.19	11.73	17.06	8.00	4.27	0.00	12.80	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	70.11	36.56	30.84	13.99	17.15	7.52	6.17	1.05	21.81	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	75.91	43.70	36.35	18.04	17.64	7.08	6.28	0.94	21.25	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	82.17	48.51	36.25	13.98	18.82	8.29	6.90	0.69	16.57	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	89.32	49.51	33.61	14.61	18.35	8.79	5.82	0.65	17.45	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	85.18	42.95	33.25	12.13	22.81	5.10	6.07	0.24	19.17	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	83.07	45.66	32.76	17.29	17.03	5.16	4.39	0.52	20.12	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	75.65	39.56	31.33	11.71	20.57	6.96	6.96	0.32	14.56	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	68.68	43.96	22.53	15.38	19.23	7.69	5.49	1.10	15.38	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	92.65	58.47	36.54	14.85	17.92	9.90	8.49	1.65	25.46	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	77.69	36.34	33.27	11.95	16.96	6.78	4.52	0.48	16.80	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	87.23	46.87	34.38	11.94	20.63	9.95	5.79	1.45	23.34	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	74.32	47.31	28.68	12.14	18.84	7.12	3.98	1.05	16.12	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	69.36	42.20	27.74	9.57	15.83	7.23	5.86	0.39	19.15	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	85.89	45.79	35.66	9.29	14.56	4.85	6.75	0.63	9.50	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	109.85	76.04	39.09	16.49	23.26	11.88	9.57	1.98	8.74	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	68.06	48.24	30.85	11.97	18.14	8.98	5.80	1.12	18.51	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	84.51	41.20	27.02	10.73	15.90	8.62	4.41	0.57	25.29	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	82.37	48.23	30.25	13.08	15.74	8.79	6.54	0.61	20.23	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	76.36	50.37	22.77	10.28	18.94	7.66	3.63	0.40	16.52	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	92.65	57.26	32.95	14.32	19.72	8.37	5.13	0.81	18.91	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	90.98	52.09	36.01	10.80	14.88	5.76	4.80	0.48	18.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	81.87	51.99	32.23	12.23	18.59	7.53	4.94	0.47	16.70	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	102.92	57.39	35.13	15.37	18.45	8.78	5.56	0.29	10.69	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	73.18	49.56	34.38	12.02	17.50	8.22	5.06	1.27	19.19	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	76.05	48.43	29.02	12.59	16.96	6.29	5.07	0.70	18.71	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	89.14	52.60	40.36	14.66	19.47	7.83	5.62	1.20	19.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	76.31	51.88	36.99	14.19	16.75	7.21	5.35	0.47	18.84	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	74.37	47.02	35.51	11.04	17.99	8.40	3.60	0.48	23.27	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	78.09	47.69	36.36	10.43	15.80	5.96	5.07	1.19	23.55	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	71.33	45.00	32.55	11.25	18.19	4.55	4.79	1.91	17.47	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	72.59	49.74	27.70	9.10	15.77	8.09	4.45	1.21	18.40	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	41.40	45.91	23.77	11.48	13.73	8.81	5.74	0.61	14.76	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.14	56.04	19.57	11.34	16.01	6.89	6.23	1.11	15.12	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	559.69	853.52	223.87	41.98	181.90	111.94	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.71	37.97	25.90	7.81	17.39	5.68	4.61	1.77	9.94	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	40.43	34.46	26.84	10.27	15.91	4.97	2.98	1.66	12.59	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	157.72	325.51	62.92	37.75	57.05	31.04	20.13	13.42	5.03	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	67.51	100.57	22.04	21.58	20.21	11.48	7.35	3.67	6.43	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.66	33.71	23.66	10.37	12.96	7.13	4.86	1.30	12.64	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.52	27.94	14.13	7.71	11.88	4.18	1.93	0.32	12.53	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	42.75	65.38	24.83	16.66	15.09	7.54	8.17	1.57	10.06	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	46.53	35.96	30.32	8.46	18.33	6.35	2.82	0.00	3.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	34.21	35.89	26.92	11.78	17.95	7.29	5.05	0.56	3.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	47.77	73.25	21.50	32.64	18.31	16.72	6.37	3.98	1.59	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.78	49.95	15.29	12.91	12.23	8.49	6.12	1.70	2.04	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.52	27.29	14.95	13.00	12.67	3.57	3.90	0.97	6.17	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.98	25.91	19.52	15.97	9.58	8.87	3.19	1.42	3.90	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	565.74	517.25	226.30	145.48	193.97	48.49	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	513.34	600.21	229.03	134.26	126.36	86.87	47.38	55.28	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	49.73	31.69	33.64	14.63	20.48	12.68	3.90	0.98	4.88	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	50.58	34.22	41.65	14.88	19.83	9.42	6.94	1.98	4.46	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	59.11	26.74	35.65	10.32	14.54	8.91	4.69	0.94	4.69	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	32.79	41.73	27.16	16.56	13.25	6.62	5.30	0.99	2.65	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	40.83	35.26	34.03	14.85	16.09	11.75	4.33	0.62	3.40	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	44.94	33.94	33.33	14.98	14.68	7.34	4.89	2.14	3.67	1.53
Adipocyte - breast, donor1	11376-118A8	118.00	117.68	54.01	8.24	14.25	3.64	3.80	2.69	0.79	2.85
Adipocyte - breast, donor2	11327-117E4	78.29	63.53	32.89	4.33	7.86	3.05	1.44	2.09	3.21	2.41
Adipocyte - omental, donor1	11473-119C6	95.42	132.57	46.69	4.58	13.23	2.42	3.31	2.29	1.15	2.93
Adipocyte - omental, donor2	11474-119C7	47.84	70.26	20.93	0.00	5.98	3.74	2.24	2.99	3.74	1.49
Adipocyte - omental, donor3	11475-119C8	33.83	34.50	14.07	3.68	7.37	3.01	2.01	2.01	6.36	0.33
Adipocyte - perirenal, donor1	11476-119C9	42.11	57.42	14.67	1.91	6.38	1.91	2.55	0.64	2.55	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	28.59	4.40	4.40	0.00	0.00	2.20	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	55.10	68.20	35.68	0.45	9.94	1.81	1.35	0.45	0.00	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	34.76	28.67	16.51	3.65	2.09	0.00	0.35	0.70	0.35	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	54.96	65.13	59.26	13.10	6.45	1.56	1.37	3.32	0.78	2.15
Adipocyte differentiation, day04, donor2	13022-139D7	23.94	47.10	21.36	10.55	7.46	2.06	2.57	1.80	0.00	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	45.16	47.11	30.11	11.43	7.81	1.95	2.79	3.90	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	41.15	43.50	23.51	8.23	8.82	4.11	1.76	2.35	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	107.70	125.07	46.49	8.93	19.30	2.01	2.90	1.61	3.86	5.39
Adipocyte differentiation, day08, donor2	13023-139D8	40.02	47.12	25.17	15.17	7.42	1.29	2.26	0.97	0.00	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	38.92	59.18	23.99	5.33	5.87	2.67	1.60	0.53	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	37.84	51.19	21.70	7.23	6.12	2.78	1.67	4.45	1.67	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	54.90	59.06	27.86	4.16	9.15	3.33	1.66	1.25	8.32	5.41
Adipocyte differentiation, day12, donor2	13024-139D9	41.44	62.29	25.87	9.04	6.03	2.01	2.76	1.00	1.00	2.76
Adipocyte differentiation, day12, donor3	13027-139E3	36.00	47.78	20.29	6.22	8.51	2.62	2.62	0.98	2.29	4.25
Adipocyte differentiation, day12, donor4	13030-139E6	45.37	58.15	21.01	4.26	6.09	1.83	1.22	0.61	2.74	2.44
Alveolar Epithelial Cells, donor1	11510-119G7	135.47	58.12	51.49	16.57	9.28	1.10	1.10	0.88	3.54	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	20.08	6.45	4.66	7.53	3.23	0.36	0.72	0.36	1.43	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	9.58	11.98	5.99	2.40	0.00	0.00	2.40	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	183.14	60.63	68.00	17.27	19.25	3.06	3.06	1.80	8.28	2.70
Amniotic Epithelial Cells, donor2	11613-122A2	80.33	18.41	26.78	5.02	18.41	3.35	1.67	0.00	10.04	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	116.28	39.03	51.16	11.51	12.53	3.29	1.85	0.82	7.60	1.64
Anulus Pulposus Cell, donor1	11248-116E6	104.59	103.44	69.69	16.36	29.98	7.21	7.21	4.23	1.83	4.46
Anulus Pulposus Cell, donor2	11463-119B5	38.94	29.88	27.43	5.88	13.22	3.43	2.20	1.47	2.69	2.69
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	45.83	51.22	29.65	3.15	14.83	4.49	7.19	1.80	2.25	4.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	53.83	71.20	29.52	7.81	12.16	2.60	5.21	3.47	2.17	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	72.77	51.37	34.24	6.42	17.12	6.42	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	46.33	69.65	31.69	4.18	13.75	3.89	2.99	4.78	2.99	2.99
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	73.35	31.62	3.79	12.65	2.53	6.32	5.06	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.75	51.49	25.08	1.98	11.88	3.96	5.28	0.66	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	46.13	50.03	23.39	3.57	13.00	2.60	3.25	1.30	1.62	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	40.78	61.17	24.76	3.40	9.71	3.88	6.31	3.40	0.00	2.91
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	71.27	61.76	45.13	2.97	7.72	4.16	4.75	2.97	2.97	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	42.94	63.65	25.61	4.14	19.96	4.90	6.03	2.64	3.01	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	42.81	55.88	30.48	2.18	13.79	2.18	0.73	4.35	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	46.39	50.15	28.84	1.25	8.78	2.51	5.02	3.76	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	138.71	103.29	66.55	4.28	20.43	3.62	4.61	2.64	1.81	3.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	55.96	12.28	4.09	15.01	8.19	5.46	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	82.63	64.24	38.30	4.83	11.01	2.71	2.71	3.17	1.36	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	32.15	64.83	24.65	5.36	21.43	3.75	5.36	2.14	2.68	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	70.66	57.25	36.09	2.83	11.15	4.35	3.97	2.08	2.83	2.27
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	75.91	63.61	37.15	3.74	13.63	3.21	4.01	1.60	1.07	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	48.77	27.31	0.98	19.51	0.98	3.90	1.95	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	67.34	62.53	32.51	4.15	13.77	2.99	4.81	2.99	1.16	2.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	49.23	54.03	22.81	1.20	3.60	4.80	0.00	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	56.64	10.62	3.54	10.62	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	62.61	62.27	28.30	4.12	12.01	2.06	3.60	2.40	2.57	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	50.34	16.78	4.19	8.39	0.00	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	35.92	62.13	25.24	3.88	14.56	1.46	6.31	2.43	0.97	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	61.85	60.71	33.77	4.93	6.45	5.31	3.79	1.90	3.79	3.42
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	59.36	46.03	25.44	2.42	10.90	3.63	4.85	2.42	1.21	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.33	67.26	18.81	1.71	15.96	2.85	5.13	2.28	2.85	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	60.71	51.31	30.57	4.92	13.04	3.42	3.85	1.92	1.71	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	59.10	53.68	29.16	2.84	6.19	1.81	3.87	1.55	2.06	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	45.51	51.61	23.46	2.82	13.14	4.22	3.28	2.82	2.35	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	59.17	61.74	34.41	3.86	13.18	2.25	1.61	1.93	1.93	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	68.49	53.51	37.10	2.14	5.71	3.57	0.71	2.85	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	39.19	47.97	26.91	1.75	11.11	2.92	4.68	1.75	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	56.00	57.50	31.91	3.61	9.63	3.01	3.61	3.01	2.71	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	49.90	57.02	23.76	4.75	11.88	2.38	3.56	0.00	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	51.87	79.34	28.48	6.10	20.34	3.05	7.63	5.59	3.56	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	64.95	66.47	42.53	3.31	11.21	4.84	3.57	2.04	2.55	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	54.64	64.81	34.95	1.91	4.45	1.27	5.72	0.64	3.18	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.54	52.65	28.48	5.18	10.36	4.32	6.47	4.32	2.59	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	56.94	49.11	35.35	4.02	14.18	4.23	3.39	3.60	1.91	2.33
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.58	42.92	26.10	2.90	11.60	2.61	2.61	2.03	1.16	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	33.07	54.79	34.01	5.67	15.12	2.83	4.72	2.83	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	62.55	51.54	33.06	4.41	14.92	2.54	3.05	2.03	2.71	2.37
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	53.28	69.49	32.43	4.63	11.58	2.32	9.27	0.00	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	67.60	29.58	6.34	21.13	6.34	6.34	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	57.25	54.46	34.95	3.65	14.58	1.93	2.79	3.43	3.00	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	62.57	57.76	39.11	6.62	11.43	1.80	3.01	1.20	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	40.82	62.69	21.87	2.19	11.66	3.64	6.56	0.73	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	69.19	77.24	40.69	4.83	13.79	3.22	3.91	3.22	2.76	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	63.76	76.51	33.15	2.55	12.75	0.00	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	78.81	75.51	39.91	5.59	11.19	2.03	3.81	2.80	2.29	2.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	67.92	65.23	34.89	4.13	14.24	2.06	3.30	2.48	1.65	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	64.26	62.12	34.27	2.75	7.65	3.37	2.45	2.45	2.45	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	44.93	76.48	30.11	4.78	18.16	4.30	4.78	4.78	0.48	3.35
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	60.76	58.10	35.26	3.10	12.86	2.00	2.00	1.77	2.00	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	73.24	71.71	21.36	3.05	16.78	1.53	4.58	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	35.45	57.05	29.36	3.32	14.40	2.22	2.22	2.22	0.55	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	55.87	54.28	32.57	2.38	11.12	3.71	2.12	3.18	1.59	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	52.70	49.79	27.26	2.54	7.27	2.54	2.54	1.45	1.45	1.45
Astrocyte - cerebellum, donor1	11500-119F6	76.39	69.51	35.99	5.53	29.60	3.07	3.93	1.47	3.93	0.86
Astrocyte - cerebellum, donor2	11580-120F5	36.29	16.26	18.83	3.42	9.07	1.20	1.37	0.51	1.71	0.68
Astrocyte - cerebellum, donor3	11661-122F5	32.93	10.70	18.67	2.73	6.50	0.63	1.89	0.00	1.05	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	179.17	136.65	96.91	10.81	94.12	21.26	26.14	1.74	6.97	12.55
Astrocyte - cerebral cortex, donor2	11316-117D2	174.55	96.74	98.68	10.52	76.52	21.68	20.38	2.10	6.96	5.66
Astrocyte - cerebral cortex, donor3	11392-118C6	147.52	85.62	76.22	7.31	53.70	13.87	17.30	0.45	2.68	6.56
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	122.83	113.77	61.70	174.32	19.27	8.03	5.28	11.35	3.78	3.21
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	143.95	118.39	75.42	170.26	18.17	8.27	5.51	9.52	5.01	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	136.78	109.02	70.67	158.97	16.39	7.28	5.01	8.42	4.55	2.28
Basophils, donor1	12241-129G9	274.09	219.43	75.32	75.32	4.97	0.78	0.78	18.05	0.78	0.52
Basophils, donor2	12242-129H1	336.62	483.47	96.69	150.09	9.38	2.16	1.80	23.81	0.00	1.80
Basophils, donor3	12243-129H2	185.36	189.19	68.21	51.16	3.23	1.32	0.73	7.94	1.18	1.62
Bronchial Epithelial Cell, donor1	11511-119G8	131.95	38.38	64.90	23.50	6.25	1.29	0.65	1.08	4.74	1.51
Bronchial Epithelial Cell, donor2	11591-120G7	18.74	4.11	8.69	5.49	1.37	0.46	0.00	0.00	2.29	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	21.52	93.26	14.35	0.00	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	69.04	39.54	37.66	21.97	8.16	3.14	1.26	0.63	3.77	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	64.05	32.23	31.61	16.01	2.29	0.83	1.25	0.21	1.04	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	90.50	28.79	52.51	49.05	11.28	1.61	1.15	0.46	1.38	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	102.93	43.91	80.44	35.99	16.55	7.20	2.52	1.80	7.56	1.80
Burkitt's lymphoma cell line:DAUDI	10422-106C8	133.15	71.93	105.94	197.35	27.52	5.46	4.84	5.56	5.46	6.60
Burkitt's lymphoma cell line:RAJI	10476-106I8	135.08	144.63	100.15	64.28	25.62	7.22	3.73	3.73	1.63	5.12
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	70.03	51.48	53.40	56.60	37.41	8.95	9.59	5.12	4.48	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	361.97	62.05	93.08	51.71	20.68	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	164.56	186.54	46.21	62.55	5.07	0.00	0.56	8.45	1.13	1.69
CD14+ Monocytes, donor2	11305-117B9	129.18	127.69	42.13	50.30	1.86	0.19	0.56	4.08	1.48	0.74
CD14+ Monocytes, donor3	11381-118B4	157.63	123.38	36.00	44.35	1.98	1.32	0.44	6.37	1.98	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	94.82	117.18	63.97	29.15	7.64	1.98	0.85	4.53	0.28	5.38
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	119.41	105.38	87.95	54.21	16.30	1.14	3.79	5.69	0.38	3.79
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	137.08	118.68	87.12	39.45	9.53	0.99	2.63	5.59	0.33	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	258.02	250.65	66.64	62.45	8.38	0.58	1.16	6.22	0.29	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	263.12	196.43	68.50	45.56	10.86	1.21	1.51	5.73	0.30	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	238.55	185.96	80.54	37.19	9.24	0.47	1.66	5.45	0.95	2.13
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	239.21	222.30	67.29	39.67	6.19	0.50	0.67	3.52	0.33	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	311.07	194.86	78.11	28.98	10.49	0.55	2.21	3.86	0.55	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	375.12	268.26	94.96	34.21	13.64	0.50	0.00	2.98	1.49	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	324.05	211.27	83.61	41.31	9.99	0.20	0.20	4.11	0.39	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	311.41	194.07	74.25	48.43	11.40	0.89	1.78	3.56	0.36	1.78
CD14+ monocytes - treated with BCG, donor3	11880-125C8	541.03	369.54	140.59	53.32	26.99	1.52	2.39	7.18	1.09	2.83
CD14+ monocytes - treated with Candida, donor1	11868-125B5	250.98	230.61	58.77	37.69	3.75	0.23	0.23	3.51	0.23	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	314.70	270.88	89.76	39.07	4.22	1.06	0.53	5.28	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	318.39	242.95	68.78	41.05	5.55	0.00	2.22	1.11	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	285.75	284.11	76.75	54.74	8.03	0.30	0.45	3.72	0.30	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	373.55	271.38	98.38	40.91	21.15	0.60	1.20	6.19	1.60	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	504.67	409.94	129.71	43.51	18.95	0.62	1.46	6.45	0.21	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	394.20	341.35	87.62	50.56	10.07	0.46	1.37	5.72	0.23	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	415.31	372.11	121.70	41.17	16.51	1.81	1.58	4.07	0.90	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	367.06	254.89	93.40	29.68	13.09	0.87	2.62	3.06	0.44	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	228.64	197.98	80.16	45.19	9.15	0.27	1.08	5.92	0.27	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	306.00	206.56	82.00	60.36	12.39	0.35	1.22	3.31	0.70	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	308.88	212.09	87.95	49.24	13.47	0.00	2.52	3.37	0.84	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	327.37	281.08	84.51	35.27	5.14	0.37	1.10	3.67	0.00	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	414.26	210.65	78.56	21.49	5.64	1.06	1.06	5.99	0.70	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	405.38	248.32	85.55	21.94	6.58	0.00	0.88	5.70	1.32	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	242.55	216.40	73.93	42.72	9.59	0.52	0.52	3.66	0.87	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	261.66	213.34	77.31	35.31	7.43	0.00	0.00	2.23	1.49	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	524.22	404.80	125.45	60.78	23.71	2.16	1.94	6.90	1.72	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	233.82	220.71	70.84	27.44	3.69	1.23	0.82	6.96	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	337.27	321.51	87.62	28.74	8.34	0.46	0.93	5.56	0.23	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	396.24	348.68	108.11	27.38	6.96	0.93	1.39	6.26	0.46	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	205.32	194.86	93.51	48.39	2.40	0.44	0.44	7.85	0.00	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	197.04	208.36	75.07	51.51	2.77	0.00	0.46	7.39	0.23	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	166.36	161.38	80.36	30.11	1.73	0.43	0.00	8.01	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	191.07	178.30	113.99	63.22	3.43	0.31	0.31	11.99	0.31	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	168.18	170.45	86.62	48.03	3.67	0.52	0.35	8.38	0.35	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	171.69	184.17	101.67	58.19	2.90	0.45	0.22	11.15	0.00	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	159.23	150.04	64.05	66.86	2.81	0.00	0.26	3.83	0.00	1.53
CD14-CD16+ Monocytes, donor2	11800-124C9	191.90	221.10	60.38	75.97	3.73	0.44	0.22	4.39	0.00	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	206.97	219.60	75.59	81.48	4.21	0.21	1.05	6.11	0.00	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	221.52	160.55	126.00	315.01	4.06	0.00	2.03	22.36	4.06	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	221.02	176.95	131.53	290.17	6.10	3.39	1.36	22.37	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	221.62	155.34	142.91	308.61	11.39	4.14	7.25	18.64	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	193.49	180.70	110.87	286.24	9.06	1.60	0.53	20.26	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	234.80	214.43	149.56	379.00	8.04	3.22	3.22	27.34	0.54	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	172.68	168.47	139.69	295.52	9.13	0.70	2.81	25.97	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	215.70	149.81	129.42	320.80	6.27	0.78	0.78	18.04	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	220.15	187.20	129.19	304.52	9.23	3.95	1.32	27.68	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	167.67	241.64	63.29	180.00	9.04	2.47	4.11	11.51	7.40	4.93
CD19+ B Cells, donor2	11624-122B4	195.87	248.82	59.49	150.16	13.06	2.18	2.90	11.61	5.08	0.73
CD19+ B Cells, donor3	11705-123B4	192.84	254.94	45.43	176.18	9.59	5.05	4.04	8.08	5.05	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	51.32	80.41	36.37	23.03	7.68	2.42	0.81	5.66	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	42.35	51.53	27.56	19.97	6.39	2.00	1.60	4.39	0.40	1.20
CD34+ Progenitors, donor1	11545-120B6	80.32	156.63	47.19	43.17	26.11	7.03	10.04	8.03	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	151.13	278.66	46.63	55.06	28.09	5.62	11.24	13.48	5.06	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.76	65.38	74.40	55.99	29.68	4.51	6.01	8.27	1.88	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	77.34	74.18	72.15	70.35	31.79	5.19	8.12	6.76	2.25	0.68
CD4+ T Cells, donor1	11225-116C1	393.12	328.85	121.76	325.28	7.14	2.50	5.00	27.49	2.50	1.43
CD4+ T Cells, donor2	11306-117C1	244.95	218.00	90.02	221.06	4.90	3.06	1.22	20.21	6.12	2.45
CD4+ T Cells, donor3	11382-118B5	280.29	214.72	84.48	239.42	3.96	0.91	1.83	23.18	4.88	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	140.89	150.33	110.52	309.35	3.83	1.53	0.77	35.99	0.51	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	161.71	140.15	117.91	289.06	3.37	0.67	0.00	29.65	0.22	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	144.88	126.77	122.75	281.14	2.87	1.15	1.44	30.18	0.00	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	228.04	235.62	89.13	241.79	3.79	1.90	0.95	24.65	1.42	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	214.21	196.65	113.07	262.67	7.02	0.00	1.40	29.50	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	194.48	108.78	95.59	220.85	6.59	0.00	3.30	13.18	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	161.13	187.58	90.32	295.68	5.49	0.87	1.16	30.49	0.29	2.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	129.47	106.25	79.82	225.39	5.42	1.19	0.85	18.64	0.34	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	131.71	96.24	81.89	186.03	4.03	0.97	0.81	17.25	0.97	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	187.39	218.32	98.63	272.57	5.83	2.24	1.34	42.59	0.00	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	196.71	205.09	117.05	307.46	4.54	0.70	0.35	48.91	0.00	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	211.63	227.47	125.39	324.27	3.08	0.00	0.88	59.40	0.00	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	134.93	154.32	117.64	279.97	2.95	0.42	2.53	16.44	0.42	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	99.31	75.63	74.59	169.54	1.45	1.87	1.04	10.18	0.42	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	87.88	79.86	74.18	146.68	2.00	2.00	0.00	11.36	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	283.36	188.99	126.18	286.35	2.72	2.18	1.63	23.66	1.36	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	270.65	211.70	126.48	326.93	6.43	2.14	1.61	29.48	1.07	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	249.26	143.46	105.80	216.98	7.17	0.00	1.79	21.52	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	185.43	173.19	137.22	335.63	5.01	2.41	0.56	17.80	0.37	3.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	152.07	145.57	97.04	273.15	6.28	2.38	0.65	18.85	0.00	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	167.49	148.58	111.17	277.40	5.88	1.68	1.68	19.54	0.42	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	263.93	187.07	122.86	269.49	2.02	1.01	1.01	25.79	3.54	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	267.75	200.60	123.48	296.78	3.47	1.30	0.87	31.19	1.30	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	277.61	249.29	167.79	322.50	3.92	2.18	2.18	55.78	0.87	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	238.53	166.28	200.42	355.32	9.90	1.98	3.46	43.05	0.99	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	181.87	149.56	125.55	285.26	7.39	1.85	1.85	48.01	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	196.81	150.75	170.29	266.60	8.37	1.40	1.40	41.87	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	129.05	211.57	91.39	288.28	7.20	2.49	2.49	52.89	1.66	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	160.73	245.88	114.11	348.70	6.38	2.70	1.96	65.52	0.74	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	231.00	237.16	221.76	332.64	13.86	3.08	0.00	41.58	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	260.35	200.19	188.01	340.93	6.45	1.07	1.07	43.69	0.00	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	253.45	192.51	174.51	311.62	6.92	1.38	1.38	49.86	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	353.91	440.35	103.13	214.77	12.77	2.95	4.26	33.39	4.58	0.98
CD8+ T Cells, donor2	11307-117C2	248.16	214.75	68.70	159.93	8.26	2.25	1.50	20.65	6.38	1.13
CD8+ T Cells, donor3	11383-118B6	299.20	262.08	79.79	170.94	7.32	4.29	3.28	20.45	5.30	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	72.26	103.91	26.61	16.52	31.66	4.13	4.13	4.82	1.61	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	88.43	105.68	24.68	20.13	33.55	4.55	5.75	7.91	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	90.29	109.44	42.95	18.33	39.12	4.92	7.39	3.83	1.92	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	80.16	144.70	36.03	27.62	44.13	4.80	9.61	6.60	0.90	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	76.79	91.43	27.84	19.20	30.00	3.60	4.80	4.80	1.20	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	70.72	95.50	30.24	19.33	31.61	4.55	5.23	5.46	2.05	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	65.62	92.56	29.33	13.91	34.33	5.65	7.17	5.65	2.39	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	67.91	98.44	28.16	11.32	30.79	2.37	5.79	4.47	2.37	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	68.71	95.21	30.25	14.54	32.13	4.22	5.39	4.69	3.28	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	71.85	121.35	26.57	24.45	40.45	8.75	5.13	6.94	2.42	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	70.01	116.78	26.44	30.79	32.54	2.91	4.94	2.91	1.74	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	76.20	115.90	27.44	24.78	26.91	4.53	4.80	3.46	3.46	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	75.29	113.38	18.82	14.01	25.83	2.19	3.94	2.19	5.69	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	67.86	126.61	15.94	17.31	30.06	4.10	6.38	4.10	5.47	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	59.67	82.05	17.16	18.65	16.41	3.73	2.98	1.49	5.22	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	73.11	100.12	18.37	19.81	37.82	3.60	4.32	3.96	2.16	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	69.92	91.78	27.91	17.84	34.53	4.60	6.91	5.75	1.73	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	73.07	93.81	30.64	19.09	31.11	3.30	5.66	5.42	1.89	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	71.94	120.11	25.35	16.48	40.56	6.34	7.29	5.39	1.27	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	61.21	96.88	20.61	13.84	34.45	5.54	6.15	4.00	1.85	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	56.74	90.40	23.40	17.63	33.66	5.13	6.41	5.13	1.60	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	54.31	113.97	18.74	18.36	37.10	3.06	5.35	6.12	1.91	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	55.57	96.16	17.34	18.52	24.43	1.58	5.12	4.73	2.76	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	55.97	96.82	30.26	18.91	21.94	0.76	5.29	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	65.84	115.63	21.68	20.88	27.30	4.01	4.01	7.23	10.44	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	60.15	111.91	23.08	30.08	21.68	2.80	3.50	6.29	8.39	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	53.09	122.21	24.04	19.03	21.04	6.01	2.00	10.02	8.01	1.00
Cardiac Myocyte, donor1	11525-119I4	47.52	60.32	16.45	5.48	3.66	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	44.96	43.97	20.26	3.95	18.28	6.92	4.45	2.96	4.45	0.99
Cardiac Myocyte, donor3	11686-122I3	118.39	74.50	51.77	9.47	19.57	5.58	5.26	3.68	2.42	3.68
Chondrocyte - de diff, donor1	11261-116G1	76.96	97.76	36.40	5.89	22.19	4.51	5.20	2.08	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	56.50	64.68	27.01	3.20	11.37	2.49	1.07	2.84	0.71	1.42
Chondrocyte - de diff, donor3	11410-118E6	84.54	64.51	40.73	9.10	9.78	3.19	2.05	1.93	0.80	1.82
Chondrocyte - re diff, donor2	11339-117F7	138.76	185.32	96.69	12.53	16.11	0.90	3.58	13.43	0.00	8.95
Chondrocyte - re diff, donor3	11411-118E7	55.00	38.01	30.73	9.30	3.64	1.62	0.40	4.04	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	200.71	206.68	101.68	24.90	91.92	25.48	26.05	3.33	9.98	6.20
Ciliary Epithelial Cells, donor2	11323-117D9	127.19	113.94	63.70	15.39	38.26	14.54	12.18	1.50	7.05	5.34
Ciliary Epithelial Cells, donor3	11399-118D4	147.61	110.80	67.26	12.39	38.32	10.89	12.66	1.77	9.38	6.02
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	80.97	72.08	59.15	45.85	30.26	5.41	5.04	4.03	2.11	4.13
Corneal Epithelial Cells, donor1	11526-119I5	72.24	19.10	32.94	19.98	4.83	0.44	1.10	0.66	2.20	0.00
Corneal Epithelial Cells, donor2	11606-120I4	106.93	37.54	61.43	38.68	5.69	5.69	0.00	0.00	6.83	1.14
Corneal Epithelial Cells, donor3	11687-122I4	129.09	38.34	65.70	28.63	6.65	2.56	2.05	0.26	2.05	1.28
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	105.17	53.16	82.22	20.80	46.06	6.44	7.43	15.19	8.58	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	102.51	64.66	69.39	23.34	41.95	3.47	7.89	10.41	10.41	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	75.92	51.76	51.76	10.35	31.06	3.45	3.45	6.90	6.90	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	72.89	30.24	50.22	17.06	33.26	4.75	6.70	8.10	12.96	1.30
Dendritic Cells - plasmacytoid, donor1	11228-116C4	323.88	408.26	117.87	121.97	20.16	4.78	4.44	11.62	0.34	3.07
Dendritic Cells - plasmacytoid, donor2	11309-117C4	281.39	412.61	97.28	140.37	18.28	1.96	5.22	13.06	0.00	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	218.74	454.42	59.53	107.44	29.52	6.29	5.32	11.13	1.45	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	153.26	88.39	54.53	17.18	17.18	2.33	2.84	4.50	1.67	2.33
Endothelial Cells - Aortic, donor1	11263-116G3	56.33	36.38	19.95	7.63	4.69	2.93	1.17	4.69	0.00	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	102.09	59.10	45.25	10.46	16.12	3.11	3.39	3.39	3.39	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	130.93	47.58	56.62	10.22	19.27	3.54	1.57	1.18	1.97	2.36
Endothelial Cells - Artery, donor1	11264-116G4	52.65	36.94	29.09	6.69	8.73	1.75	1.16	2.04	1.75	1.16
Endothelial Cells - Artery, donor2	11341-117F9	125.40	70.58	43.53	7.29	13.18	1.88	1.65	2.82	1.18	0.94
Endothelial Cells - Artery, donor3	11413-118E9	114.30	51.01	52.59	10.87	10.87	1.58	1.58	1.75	0.70	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	117.92	56.74	56.30	17.73	23.72	3.32	3.99	2.88	3.55	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	133.57	79.41	67.55	13.39	29.51	4.26	3.65	3.65	4.87	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	89.36	80.91	59.48	22.27	20.30	4.51	3.95	6.20	2.82	2.54
Endothelial Cells - Microvascular, donor1	11265-116G5	49.03	70.72	26.44	12.78	18.42	2.97	2.67	4.46	2.67	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	83.83	57.27	41.13	17.70	13.02	4.69	1.04	1.56	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	51.04	25.95	24.10	7.66	11.91	1.84	2.69	3.26	1.42	3.12
Endothelial Cells - Thoracic, donor1	11266-116G6	118.44	114.43	47.61	20.41	28.01	5.60	4.00	6.40	4.40	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	59.75	27.25	26.73	4.72	10.48	0.52	3.14	3.14	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	207.37	184.38	94.30	23.98	39.39	8.45	9.69	8.70	3.60	3.35
Endothelial Cells - Umbilical vein, donor2	11324-117E1	83.43	69.31	37.59	9.34	17.82	6.74	4.78	3.48	4.78	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	122.74	78.65	54.84	12.82	21.74	6.59	5.01	4.89	3.91	3.66
Endothelial Cells - Vein, donor1	11267-116G7	56.88	29.58	25.03	9.10	11.38	0.00	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	98.49	64.96	45.40	11.87	20.26	1.40	0.70	1.40	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	96.40	42.08	34.07	10.21	16.33	2.98	2.83	3.61	2.36	1.26
Eosinophils, donor1	12244-129H3	411.67	487.90	152.47	365.93	0.00	15.25	0.00	106.73	15.25	0.00
Eosinophils, donor2	12245-129H4	608.95	882.89	158.43	300.35	8.25	4.95	1.65	34.66	6.60	6.60
Eosinophils, donor3	12246-129H5	488.65	649.16	117.71	321.01	14.27	10.70	3.57	28.53	14.27	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	85.76	32.01	45.20	19.79	2.44	0.24	0.73	0.24	4.89	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	35.36	12.48	10.40	12.48	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	48.81	97.61	0.00	16.27	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	56.24	57.06	33.66	6.98	10.67	3.69	1.64	3.28	0.41	4.93
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	44.01	46.53	13.91	1.53	4.93	1.86	0.66	0.44	0.88	1.64
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	57.64	46.26	30.01	4.66	11.59	4.12	2.82	2.28	1.19	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	162.76	122.86	78.35	6.55	25.47	9.46	5.94	5.46	2.67	3.64
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	160.90	118.59	56.09	5.19	13.78	3.55	2.73	1.64	0.82	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	69.93	67.50	32.17	4.32	8.75	3.90	2.95	1.90	0.53	1.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	62.97	43.48	27.67	2.37	7.90	1.32	5.01	1.05	0.79	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	98.66	67.44	60.79	5.32	20.60	11.63	5.98	5.32	1.33	3.32
Fibroblast - Cardiac, donor1	11268-116G8	87.55	58.97	31.30	4.08	14.52	5.90	1.36	4.54	6.35	3.63
Fibroblast - Cardiac, donor2	11345-117G4	87.16	62.15	43.20	2.27	9.10	1.52	0.76	0.76	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	79.33	45.58	27.60	4.57	8.36	3.94	2.37	1.26	9.62	1.58
Fibroblast - Cardiac, donor4	11452-119A3	87.90	101.54	45.47	3.33	14.85	6.67	5.15	2.12	1.52	2.73
Fibroblast - Cardiac, donor5	11456-119A7	65.74	83.50	32.74	8.38	14.72	4.95	4.31	3.68	1.78	1.78
Fibroblast - Cardiac, donor6	11460-119B2	73.67	79.44	30.32	4.09	14.70	4.24	2.27	2.88	3.49	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	64.72	67.93	22.78	4.96	11.12	2.55	3.22	0.94	0.67	2.14
Fibroblast - Choroid Plexus, donor2	11572-120E6	50.48	49.18	28.47	2.59	7.33	5.18	5.61	0.00	1.29	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	68.85	70.31	45.41	5.86	29.30	8.79	8.79	0.00	1.46	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	104.02	52.59	43.82	8.76	13.15	1.38	0.92	1.15	0.23	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	99.39	88.87	66.99	9.67	30.19	2.71	5.09	1.36	0.68	3.73
Fibroblast - Dermal, donor1	11269-116G9	44.37	47.66	26.06	1.41	7.51	2.35	2.11	1.41	0.70	0.94
Fibroblast - Dermal, donor2	11346-117G5	92.92	84.90	51.41	4.72	13.68	3.77	4.25	4.25	0.94	2.36
Fibroblast - Dermal, donor3	11418-118F5	79.54	70.72	44.85	2.42	8.95	2.18	2.42	2.30	0.24	1.69
Fibroblast - Dermal, donor4	11450-119A1	83.20	85.80	48.84	7.23	16.96	2.83	3.84	3.84	0.45	2.71
Fibroblast - Dermal, donor5	11454-119A5	95.25	87.23	54.95	8.37	18.84	3.31	4.88	3.49	0.00	1.92
Fibroblast - Dermal, donor6	11458-119A9	102.33	100.05	55.39	8.77	21.44	2.60	5.04	2.76	0.32	4.06
Fibroblast - Gingival, donor1	11237-116D4	130.77	130.98	64.55	7.70	17.07	4.16	5.83	2.92	1.25	2.92
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	97.99	96.94	56.07	4.72	32.23	8.91	9.43	4.98	4.19	3.14
Fibroblast - Gingival, donor2	11318-117D4	154.71	126.51	77.23	9.22	40.98	8.83	9.09	4.22	3.69	3.29
Fibroblast - Gingival, donor3	11394-118C8	114.48	78.41	56.56	5.22	14.31	3.58	2.90	2.42	0.77	2.32
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	97.66	121.55	41.56	0.00	8.31	6.23	1.04	0.00	0.00	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	60.09	45.99	31.54	2.82	5.11	2.64	1.06	2.11	0.70	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	166.03	124.56	85.43	6.39	29.78	9.35	10.91	3.27	1.87	4.37
Fibroblast - Gingival, donor6 (control)	11922-125H5	149.83	123.06	81.68	5.14	31.64	7.71	8.52	3.79	2.30	3.52
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	51.87	51.87	29.64	3.18	11.65	3.18	5.65	1.76	0.71	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	126.50	107.34	61.72	3.66	21.79	5.70	5.85	3.07	0.44	3.22
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	161.31	131.31	78.40	6.14	31.22	9.54	8.32	4.23	2.18	3.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	146.99	108.93	70.42	4.17	23.58	7.13	5.48	2.63	1.10	3.18
Fibroblast - Gingival, donor9 (control)	11927-125I1	65.01	63.39	39.91	3.67	14.09	2.20	2.05	2.35	0.59	2.64
Fibroblast - Lung, donor1	11270-116H1	29.91	32.62	13.59	2.72	6.80	1.36	0.00	2.72	0.00	4.08
Fibroblast - Lung, donor2	11347-117G6	98.48	128.33	73.12	4.48	20.89	8.95	5.97	1.49	1.49	5.97
Fibroblast - Lung, donor3	11419-118F6	97.50	73.02	48.75	6.75	15.19	5.49	3.59	1.69	1.06	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	80.80	57.48	22.49	0.83	5.83	1.67	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	36.36	33.57	18.18	1.40	1.40	0.00	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	20.15	9.24	7.28	1.12	1.40	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	122.20	106.77	66.98	6.50	12.59	1.62	2.44	0.00	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	31.95	11.98	15.98	7.99	11.98	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	83.39	29.78	29.78	5.96	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	176.52	184.86	92.91	16.29	39.96	7.37	8.34	4.46	0.97	5.04
Fibroblast - Periodontal Ligament, donor2	11319-117D5	173.22	123.92	79.48	9.10	29.58	7.89	7.74	4.85	0.76	3.34
Fibroblast - Periodontal Ligament, donor3	11395-118C9	175.02	187.26	107.40	6.73	19.58	4.28	7.96	4.28	2.45	3.98
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	93.50	62.59	48.08	1.91	14.88	4.96	2.67	2.67	1.53	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	117.45	90.72	47.79	2.43	9.99	4.59	3.78	3.24	0.81	3.24
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	67.50	42.68	32.70	3.02	5.91	1.97	1.86	2.20	0.81	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	200.62	124.90	94.62	6.96	25.98	8.40	5.31	5.08	4.86	3.87
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	145.89	68.88	57.91	3.66	10.57	2.84	1.83	0.61	1.63	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.12	29.40	30.07	2.00	6.68	2.00	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	71.17	41.12	44.68	3.95	20.56	2.77	4.74	1.58	0.00	3.16
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	106.96	85.73	48.82	2.58	20.44	3.77	4.76	2.38	0.99	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	90.94	78.33	47.60	4.26	14.92	3.91	3.37	1.78	0.71	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	107.21	126.73	69.97	2.56	17.34	6.31	4.73	1.97	0.39	2.17
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	83.94	69.20	33.70	2.11	12.03	2.11	3.91	1.50	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	122.63	182.44	52.03	4.64	27.10	7.56	6.69	7.56	2.48	1.94
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	91.87	85.29	51.63	1.77	14.17	4.30	5.31	1.52	0.76	0.76
Fibroblast - skin normal, donor1	11553-120C5	117.97	136.02	47.42	6.73	16.57	8.86	6.23	4.10	2.63	2.95
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	131.73	96.84	67.77	4.01	18.25	2.01	1.60	1.60	0.60	1.00
Fibroblast - skin normal, donor2	11561-120D4	126.38	187.36	51.64	5.22	28.13	8.04	7.13	7.23	2.91	3.62
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	125.13	116.36	59.84	4.53	22.67	6.65	10.58	1.21	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	119.55	131.23	57.41	5.55	16.98	5.55	6.30	2.65	1.08	1.57
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	67.87	147.53	35.56	5.98	25.47	6.67	6.84	3.76	0.85	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	76.85	68.31	31.53	1.97	11.17	4.60	3.94	0.99	0.66	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	140.40	214.85	54.33	6.07	24.50	10.44	9.91	7.24	3.52	3.94
Fibroblast - skin walker warburg, donor1	11554-120C6	184.03	135.11	83.83	8.43	27.83	10.12	9.28	4.05	3.04	2.19
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	114.48	130.63	41.56	8.47	18.19	8.47	3.61	4.86	2.51	2.35
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1329.59	2171.66	288.08	0.00	332.40	88.64	88.64	265.92	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	104.58	71.47	74.08	111.56	21.79	6.10	4.36	4.36	4.36	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	317.94	147.53	184.97	53.57	34.15	6.24	7.28	1.91	20.80	6.93
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	301.62	173.32	176.18	61.16	37.21	7.29	7.29	2.34	25.50	5.47
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	260.11	136.44	162.51	51.10	33.73	5.62	7.15	1.28	32.71	5.88
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	63.54	62.78	49.76	35.98	62.78	12.25	8.42	0.00	18.37	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	95.07	95.71	72.10	46.58	63.17	12.76	9.57	4.47	8.93	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	108.40	91.28	61.62	71.32	65.04	14.26	9.13	5.13	12.84	7.70
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.19	74.18	39.98	27.58	112.78	21.23	19.85	2.48	14.06	6.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	59.36	61.88	62.33	21.92	71.01	15.75	15.75	1.83	29.23	4.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	63.40	71.33	38.24	51.71	48.15	17.44	10.90	2.97	13.47	5.35
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	48.90	75.86	45.20	24.85	103.62	21.41	15.86	2.64	12.42	4.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	60.99	60.66	38.81	22.83	79.25	15.33	16.96	0.65	34.90	8.15
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	70.31	85.35	38.47	66.78	50.41	7.08	7.08	2.65	10.17	4.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	78.58	49.46	94.83	47.77	77.02	18.37	13.85	2.54	9.89	5.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	93.10	34.23	81.27	43.72	60.46	16.87	10.84	1.72	12.19	5.30
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	101.81	42.17	106.11	34.12	53.19	12.36	7.79	1.88	9.13	5.64
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	147.68	86.85	105.43	55.50	92.67	13.63	13.75	3.10	18.34	3.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	136.21	87.07	110.60	55.65	105.90	22.15	18.00	1.66	31.42	4.29
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	151.26	75.83	100.43	47.37	79.29	18.30	14.64	2.24	27.85	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	144.67	70.28	83.06	42.90	64.12	10.50	11.41	2.97	9.81	3.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	123.57	76.73	87.45	45.59	90.31	17.81	13.58	2.49	32.76	8.47
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	127.87	58.36	101.42	44.15	60.98	13.99	8.96	2.40	33.88	7.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	130.01	72.69	62.35	41.66	52.89	12.41	10.93	1.77	4.73	2.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	94.74	78.05	64.70	41.81	69.62	14.47	12.88	2.38	9.06	5.25
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	119.75	54.07	73.73	35.08	43.34	12.51	11.39	0.89	16.98	5.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	130.46	68.76	76.62	32.66	60.09	14.11	10.08	1.61	4.84	3.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	118.07	103.82	80.41	36.98	83.29	19.68	17.98	2.21	11.54	2.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	246.07	156.24	120.77	74.22	80.16	16.23	14.45	3.10	10.02	5.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	207.38	151.92	100.52	52.44	89.38	15.09	12.59	2.39	1.25	4.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	176.92	150.28	94.95	40.99	88.46	12.64	12.30	2.56	2.73	4.78
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	132.78	88.52	69.71	34.52	70.04	14.83	13.39	2.21	7.97	2.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	207.41	134.28	103.25	62.48	64.89	13.06	9.65	2.58	5.49	4.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	164.98	130.06	102.50	52.47	64.73	11.84	7.15	4.90	5.10	3.47
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	140.08	80.05	72.21	31.77	65.81	10.52	10.73	2.89	6.81	2.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	95.23	82.55	72.98	37.82	68.60	11.64	12.34	2.08	5.53	3.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	145.09	84.88	58.03	28.68	40.02	8.34	7.00	2.50	3.67	3.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	133.36	65.91	61.28	23.37	49.38	10.58	11.46	2.65	3.75	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	140.70	85.85	76.99	28.78	67.28	13.04	14.39	2.34	4.80	1.97
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	142.64	72.29	58.52	31.93	44.90	9.89	8.10	1.13	7.62	3.24
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	128.29	90.44	56.77	29.51	53.24	13.15	8.02	2.57	5.13	2.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	121.29	67.84	66.99	29.18	57.23	9.19	9.38	1.80	7.01	3.22
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	152.64	74.50	60.11	26.42	37.80	4.90	5.06	2.06	4.11	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	157.82	108.26	79.37	27.98	60.51	12.16	11.86	3.65	9.12	5.17
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	134.75	74.64	64.92	26.66	64.29	10.56	12.13	1.15	8.99	2.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	127.12	64.77	48.52	26.57	32.49	7.68	4.83	1.10	4.83	2.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	146.45	79.68	74.63	27.21	53.02	5.89	7.86	1.40	6.73	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	138.05	92.40	74.25	16.85	56.76	6.48	9.81	2.13	15.55	4.17
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	175.15	118.73	66.58	22.46	42.52	8.82	5.62	2.67	7.49	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	204.87	94.25	94.10	19.74	52.94	5.05	9.33	1.84	11.78	4.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	142.49	83.55	66.84	18.91	53.50	7.51	8.94	2.07	12.44	1.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	140.14	81.86	48.79	15.72	33.34	6.23	6.23	1.36	6.23	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	151.91	72.82	73.00	16.59	45.90	7.74	8.85	1.47	6.08	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	150.01	72.37	63.38	11.84	37.94	4.61	7.68	2.19	5.04	1.97
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	116.03	45.62	60.50	18.84	35.70	4.96	10.91	0.00	2.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	171.49	72.82	68.59	10.68	41.82	6.07	8.05	1.85	5.67	2.77
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	132.96	61.94	60.12	6.66	27.84	5.25	4.04	3.63	4.04	2.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	140.04	79.55	79.81	33.29	48.29	7.62	10.42	2.54	1.78	3.30
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	118.84	127.20	100.92	67.08	81.22	22.69	12.54	7.37	14.73	7.96
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	83.36	34.67	97.07	35.75	64.25	15.87	10.32	3.39	8.78	3.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	92.47	60.97	105.56	55.65	81.42	19.84	15.75	3.48	8.18	6.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	117.66	75.10	80.74	36.30	61.96	11.89	9.39	2.82	9.07	5.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	118.67	79.40	83.64	37.01	55.10	13.28	8.48	1.98	7.06	4.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	44.74	66.87	54.88	37.82	58.57	12.45	10.61	2.77	5.07	5.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	79.19	76.72	64.34	24.75	94.04	19.80	17.32	0.00	12.37	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	73.88	88.19	74.65	41.78	76.97	23.21	13.93	5.03	16.63	8.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	51.34	57.76	73.81	25.67	62.57	20.86	9.63	0.00	20.86	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	85.20	39.99	27.82	64.34	24.34	10.43	3.48	20.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	71.93	96.99	56.63	31.25	70.63	20.51	9.11	2.93	15.62	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	65.06	107.48	61.77	44.47	70.42	24.30	14.41	2.06	14.41	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	76.64	49.98	43.32	49.98	19.99	3.33	0.00	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.05	89.21	45.30	37.47	64.88	17.90	11.75	2.52	9.23	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	68.96	87.59	57.52	31.38	74.19	15.69	11.11	3.27	9.81	5.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	74.66	64.59	36.91	38.59	80.53	10.90	5.03	3.36	5.87	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	71.57	93.83	49.62	52.16	77.29	14.63	11.77	3.18	12.09	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	68.27	85.93	47.21	44.16	75.74	19.02	7.81	4.08	9.17	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	96.05	33.41	43.85	50.12	20.88	8.35	2.09	10.44	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.29	105.38	46.39	63.00	65.29	18.33	7.45	1.72	4.01	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	58.31	71.33	44.99	35.81	47.06	8.29	7.70	2.07	7.10	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	83.01	91.48	40.66	42.35	62.68	15.25	15.25	1.69	15.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	93.20	109.35	47.63	52.19	86.98	21.12	12.84	1.66	9.11	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	84.00	88.83	51.78	40.96	76.40	18.64	13.12	1.84	11.74	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	94.83	21.07	36.88	73.76	31.61	21.07	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.51	65.35	31.91	34.98	64.20	13.84	10.38	3.84	6.54	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	51.18	78.88	39.12	40.75	59.00	14.99	10.11	0.98	7.82	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	37.46	58.86	30.77	43.47	41.47	11.37	6.02	3.34	7.36	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.87	95.16	40.07	64.34	63.57	18.88	10.02	2.70	6.55	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	74.29	102.36	47.93	40.74	66.07	16.77	9.93	2.40	11.98	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	47.21	19.88	47.21	54.67	14.91	7.45	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.47	70.78	37.28	53.32	67.47	17.93	10.38	0.47	2.36	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.30	71.82	53.11	54.92	50.09	10.26	9.05	3.02	4.83	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	53.92	77.83	26.45	48.83	40.69	15.77	8.14	1.53	4.58	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	55.44	83.76	39.09	61.02	58.63	19.94	9.17	2.79	6.78	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	53.78	80.42	34.53	64.63	41.94	14.80	10.85	0.49	2.96	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	46.04	59.02	37.77	50.76	60.20	12.98	15.35	0.00	8.26	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	47.26	72.93	30.92	45.51	47.84	12.25	8.17	2.92	5.25	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.08	84.27	30.72	53.54	45.20	10.53	9.22	0.88	1.76	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	32.21	83.92	26.28	29.67	33.91	15.26	8.48	0.85	8.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	51.33	61.48	23.28	34.62	27.46	17.31	9.55	1.79	10.74	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	48.52	62.11	28.14	37.85	42.22	20.87	8.25	3.40	9.22	5.34
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	63.91	50.22	26.25	4.57	5.71	3.42	3.42	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	69.86	36.59	35.34	4.16	9.56	3.33	2.49	1.66	2.08	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	137.18	68.59	49.48	0.00	6.75	3.37	1.12	1.12	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	44.72	50.75	26.32	1.59	5.39	2.22	2.54	1.90	0.32	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	40.52	49.71	20.89	0.84	4.60	0.84	2.09	0.42	0.42	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	164.55	109.08	69.28	63.36	16.13	6.38	4.53	1.04	4.29	3.02
Hep-2 cells mock treated, biol_rep2	11899-125E9	152.26	102.63	84.74	57.73	15.02	4.56	5.91	1.69	5.40	2.36
Hep-2 cells mock treated, biol_rep3	11900-125F1	152.65	100.10	67.57	48.23	12.51	3.64	4.10	0.91	2.96	2.96
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	167.90	106.03	75.97	60.89	15.85	6.56	4.59	1.09	2.84	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	158.39	95.64	69.42	57.81	16.33	5.59	4.30	0.64	3.65	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	141.66	101.40	71.69	51.88	16.36	4.95	3.23	2.80	2.80	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	149.07	102.49	60.53	68.50	11.71	5.73	3.49	1.99	3.24	2.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	131.75	99.33	63.82	50.26	12.87	8.23	4.46	1.20	2.57	2.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	112.77	89.38	52.22	49.66	11.53	4.49	2.88	1.28	3.52	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.57	30.78	20.71	1.68	7.28	0.56	2.24	1.12	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.55	15.15	13.85	0.87	4.33	0.00	0.43	0.43	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	39.66	60.81	2.64	13.22	0.00	0.00	5.29	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	76.54	42.33	29.63	6.70	8.82	1.06	1.41	1.41	1.41	2.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	20.34	14.53	0.00	5.81	0.00	0.73	0.73	0.73	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	84.62	66.79	47.91	4.55	16.09	4.37	6.64	3.67	1.75	4.72
Hepatocyte, donor1	11523-119I2	14.53	19.37	12.11	20.58	3.63	0.00	2.42	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	18.31	32.32	20.47	36.63	8.62	1.08	1.08	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	28.22	21.47	13.50	24.54	1.84	2.45	0.00	2.45	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	125.32	91.38	81.59	141.63	38.51	9.79	10.44	4.57	3.92	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	114.66	71.14	49.11	102.25	11.89	4.54	3.50	1.92	2.62	5.07
Iris Pigment Epithelial Cells, donor1	11530-119I9	131.99	145.30	59.82	14.68	35.54	8.51	6.86	2.20	4.25	4.25
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	22.29	3.18	19.10	0.00	3.18	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	20.03	0.00	26.70	0.00	0.00	0.00	0.00	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	16.61	8.31	16.61	5.54	1.38	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	15.02	10.01	27.53	7.51	2.50	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	47.47	130.55	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	20.50	2.56	10.25	2.56	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	4.57	9.14	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	25.99	22.74	30.86	6.50	1.62	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	13.34	26.68	18.34	18.34	6.67	3.33	0.00	1.67	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	29.04	3.63	18.15	0.00	0.00	7.26	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	21.18	11.91	38.38	5.29	0.00	0.00	0.00	2.65	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	22.17	11.09	35.48	5.54	0.00	1.11	1.11	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	31.43	5.24	36.67	0.00	0.00	0.00	0.00	5.24	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	31.49	14.49	50.39	3.78	0.63	1.26	2.52	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	24.75	6.19	27.84	3.09	1.55	3.09	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	19.38	25.84	6.46	30.36	3.88	0.65	0.65	1.94	1.94	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	19.32	8.05	17.71	3.22	0.00	0.00	0.00	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	31.78	29.34	13.04	42.37	7.33	0.00	1.63	1.63	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	26.03	21.83	13.43	26.03	1.68	0.84	0.42	2.94	0.84	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	28.74	0.00	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	29.74	12.86	28.93	4.82	1.61	0.80	2.41	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	20.31	6.46	19.39	2.77	0.00	1.85	1.85	0.92	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.04	28.32	15.11	45.32	5.19	0.94	2.36	1.42	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	17.23	19.05	4.53	19.95	5.44	1.81	0.91	0.00	2.72	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	29.48	44.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	18.29	12.91	10.76	45.20	8.61	2.15	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	21.60	7.62	10.16	7.62	0.00	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	20.41	18.49	5.74	32.52	4.46	2.55	0.64	2.55	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	25.52	3.65	20.05	3.65	0.00	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	26.42	9.28	40.70	5.00	0.71	0.71	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	26.55	6.64	23.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	41.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	28.40	35.80	11.11	43.52	3.70	0.31	1.85	3.09	0.62	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	17.56	7.02	14.05	5.27	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	12.57	9.43	15.72	0.00	0.00	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.25	20.86	9.04	31.29	2.78	0.70	1.39	1.39	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	8.85	8.85	35.41	4.43	2.21	0.00	4.43	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	29.18	6.48	35.66	6.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.08	13.95	10.46	32.26	3.49	0.87	0.87	1.74	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	18.00	6.75	45.00	2.25	0.00	2.25	4.50	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	6.97	6.97	24.39	0.00	0.00	0.00	3.48	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	10.67	11.73	37.34	2.13	1.07	0.00	1.07	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	15.24	2.77	18.01	0.00	2.77	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	8.55	8.55	37.04	2.85	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	15.65	9.20	6.44	31.29	2.76	0.00	0.00	0.92	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	3.03	0.00	48.41	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	12.42	18.63	43.46	6.21	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	14.80	7.40	49.70	0.00	0.00	0.00	3.17	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	263.97	107.55	143.53	60.22	26.76	5.88	4.81	0.98	21.46	1.80
Keratinocyte - epidermal, donor2	11349-117G8	60.32	43.34	42.17	42.17	8.20	0.00	0.59	0.59	2.34	0.00
Keratinocyte - epidermal, donor3	11421-118F8	202.56	84.43	104.41	88.22	15.24	4.83	3.12	1.42	4.26	2.18
Keratinocyte - oral, donor1	11251-116E9	372.11	172.55	196.84	128.05	42.80	22.93	13.62	4.99	17.03	4.99
Keratocytes, donor1	11527-119I6	152.66	67.39	56.73	9.97	16.50	2.41	1.38	1.72	0.34	0.69
Keratocytes, donor2	11607-120I5	42.18	19.92	24.61	1.17	5.86	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	113.03	53.94	48.61	8.10	8.30	1.38	0.99	2.57	0.40	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	24.18	28.57	37.36	2.20	6.59	2.20	0.00	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	73.35	67.96	48.54	4.31	43.15	14.02	4.31	3.24	5.39	3.24
Lens Epithelial Cells, donor2	11609-120I7	162.73	143.82	86.61	22.49	76.70	14.76	14.30	2.77	7.73	4.61
Lens Epithelial Cells, donor3	11690-122I7	155.00	125.73	60.34	8.48	28.05	7.67	6.26	1.92	5.95	4.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	104.11	64.98	63.44	19.09	22.89	6.28	5.10	5.93	1.66	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	39.63	28.74	32.09	8.09	10.05	1.95	2.79	3.63	1.40	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	54.62	43.45	42.82	19.20	18.73	3.46	2.83	7.87	2.36	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	37.64	24.20	3.23	15.59	1.61	3.23	3.76	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.96	28.36	29.31	10.09	5.36	1.89	1.89	1.58	0.63	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	39.78	22.96	26.85	11.75	10.78	1.40	1.62	3.56	0.43	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.53	40.63	36.52	13.54	15.18	3.69	3.28	4.51	1.23	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	29.83	22.50	20.48	5.56	7.84	1.52	1.77	1.01	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	43.49	34.48	28.43	10.84	12.53	2.96	2.53	4.79	1.97	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	56.96	54.98	32.43	8.70	14.63	5.93	3.56	5.54	4.35	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	53.51	34.51	36.84	10.66	13.38	3.30	1.36	3.49	1.16	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	27.03	16.48	18.33	5.37	7.22	2.04	0.56	1.67	2.04	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	53.31	44.95	36.24	9.76	20.56	4.88	4.53	7.67	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.08	34.11	30.05	8.59	9.06	2.15	3.10	3.34	0.24	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	39.14	23.62	25.68	10.30	10.99	1.24	2.75	3.98	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	56.97	49.27	35.11	9.85	21.56	4.62	2.16	6.16	1.85	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.86	22.76	21.82	4.99	6.86	1.56	1.25	1.56	1.56	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	43.55	28.73	26.35	9.88	10.80	1.83	1.46	3.84	1.28	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	44.76	35.54	31.27	12.18	16.78	4.28	3.95	4.61	1.65	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.34	20.79	26.94	8.20	7.91	0.29	0.88	2.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	31.12	20.91	17.18	5.97	12.94	1.74	0.75	2.24	1.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.04	45.10	38.80	10.67	14.55	2.42	4.85	7.27	1.45	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	45.51	36.09	31.24	7.81	14.54	2.69	2.42	3.50	0.54	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	46.02	40.57	31.18	14.38	16.80	2.42	3.33	3.33	0.91	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	43.03	35.25	33.70	8.29	11.92	3.63	2.59	5.18	0.52	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	53.19	42.72	44.39	11.10	12.35	2.51	2.09	4.61	1.26	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	43.01	29.77	27.52	12.78	13.53	2.86	2.41	3.16	0.90	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	55.72	39.90	27.52	8.25	17.20	0.69	4.13	2.06	2.06	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	55.50	33.49	35.00	9.22	14.68	2.45	2.63	3.39	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	35.73	25.66	24.70	7.63	11.03	1.80	3.07	3.39	0.95	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	54.76	37.31	39.25	5.81	15.99	2.42	4.36	4.85	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	53.59	26.79	26.79	7.61	9.26	1.65	1.65	2.65	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	35.06	29.73	22.92	9.54	11.15	1.24	1.86	3.72	0.99	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	58.86	65.16	31.10	14.44	22.58	2.96	5.18	4.07	1.85	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	49.66	34.34	41.26	7.66	11.37	2.72	3.71	3.21	0.74	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	32.45	24.61	21.31	6.74	10.72	1.37	1.37	3.57	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	60.79	53.39	40.85	14.15	17.37	5.79	4.18	3.22	1.29	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	53.87	45.35	34.08	11.26	20.09	2.74	5.48	3.96	0.91	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	47.45	44.37	34.57	15.12	14.98	3.08	3.50	3.78	1.40	2.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	62.22	39.47	42.67	9.60	18.84	2.49	4.62	7.47	1.78	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	37.81	29.57	23.75	4.85	7.76	2.42	1.45	1.94	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.83	17.43	15.87	6.22	7.47	1.09	1.40	1.71	0.47	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	56.94	34.74	34.38	6.80	13.97	2.15	4.30	5.37	1.79	2.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	49.00	34.63	29.73	6.21	9.47	1.63	2.29	4.25	1.63	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.01	18.36	18.36	8.00	7.53	0.94	1.41	2.59	1.18	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	119.79	69.67	62.37	15.35	22.77	6.44	3.96	5.20	1.86	2.48
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	32.02	25.10	18.70	5.38	5.89	1.28	1.79	1.54	0.77	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	42.07	29.84	22.97	6.27	10.44	2.69	3.28	3.28	2.09	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	149.56	160.89	97.44	97.44	29.46	15.86	4.53	6.80	18.13	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	129.65	97.43	72.11	65.97	15.34	9.21	6.90	0.00	20.71	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	93.52	89.81	66.80	52.70	19.30	7.42	3.71	1.48	15.59	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	126.94	96.90	85.90	89.70	24.12	5.92	4.65	2.12	19.04	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	115.35	85.81	64.71	64.71	15.47	6.33	12.66	4.22	21.10	4.22
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	85.92	69.11	66.31	61.64	16.81	8.41	2.80	3.74	23.35	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	120.57	92.23	82.44	63.38	16.49	7.73	10.31	5.67	11.85	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	90.40	80.88	55.90	63.04	10.71	13.08	8.33	1.19	16.65	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	217.60	140.92	106.08	112.19	23.98	16.74	8.14	2.71	15.83	3.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	167.81	135.23	108.77	92.19	25.59	12.80	9.60	4.36	16.87	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	136.40	113.44	103.99	76.98	24.31	17.11	16.66	2.70	30.16	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	254.04	198.22	136.30	121.94	26.56	15.85	9.48	4.34	12.46	5.55
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	122.22	104.25	89.35	67.79	12.84	11.30	5.65	4.62	17.97	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	133.38	108.33	88.21	65.98	19.05	13.06	8.12	1.76	25.05	3.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	115.94	113.94	84.62	58.63	23.99	11.99	8.00	5.33	13.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	142.63	133.46	97.80	78.95	20.88	6.11	8.15	2.04	20.88	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	161.68	129.13	101.12	85.38	28.55	20.54	10.41	3.74	20.54	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	148.89	140.95	99.76	87.29	26.45	15.87	8.88	4.53	25.51	5.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	138.67	117.80	90.81	87.74	18.41	15.95	10.43	2.45	17.18	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	151.67	118.24	97.04	83.17	18.75	15.49	7.34	2.45	25.28	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	159.72	140.98	116.20	84.13	24.78	13.54	10.83	2.92	16.87	4.79
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	188.62	156.67	118.27	94.73	27.19	13.73	10.93	1.96	15.41	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	119.52	86.55	76.25	65.94	15.46	11.33	7.21	1.03	28.85	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	166.92	147.18	113.51	90.87	25.55	17.71	11.61	4.35	20.90	4.94
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	160.23	152.16	107.32	79.22	25.41	13.75	9.27	2.69	17.64	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	155.47	125.04	98.48	63.62	26.00	13.28	9.96	2.77	25.45	3.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	133.26	122.31	107.46	80.24	21.56	13.79	10.96	3.18	21.92	6.36
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	152.67	119.85	94.41	81.50	20.28	10.69	9.59	1.48	14.75	5.16
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	134.70	87.50	75.98	75.98	14.97	23.03	5.76	6.91	19.57	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	155.04	104.00	88.26	64.47	19.19	8.83	8.06	3.07	23.79	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	140.97	126.25	101.34	68.50	24.34	18.68	9.62	3.96	21.51	2.83
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	131.27	98.46	74.66	64.00	16.41	12.31	9.03	0.00	16.41	5.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	129.24	98.06	104.39	77.72	21.24	10.85	10.39	3.16	23.05	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	161.58	135.73	104.13	77.56	25.14	12.93	11.49	2.87	14.36	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	163.57	136.68	91.12	80.67	21.66	8.96	8.96	0.75	21.66	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	174.28	118.91	113.34	89.93	16.72	12.63	7.43	2.23	17.46	5.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	196.85	143.01	115.87	77.97	23.26	10.77	7.32	3.02	19.38	3.88
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	148.14	117.31	85.63	65.93	18.84	16.27	8.56	5.14	17.98	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	147.93	119.61	103.28	73.97	23.32	12.66	8.00	2.00	23.99	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	159.88	149.62	107.39	79.64	22.93	12.67	5.43	1.21	15.69	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	125.85	98.12	81.05	68.26	14.22	14.22	7.82	2.13	19.20	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	144.36	109.65	86.27	62.56	24.40	8.94	7.22	3.44	26.47	3.09
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	160.49	164.24	113.79	67.09	24.69	8.05	8.59	1.61	19.32	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	158.24	96.96	87.54	56.56	15.49	11.45	8.08	0.00	22.89	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	187.80	128.53	133.72	80.01	26.30	12.22	9.63	2.96	20.74	3.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	277.94	220.96	161.65	116.29	43.03	18.61	5.81	6.98	19.77	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	113.18	78.27	92.02	59.23	15.87	5.29	6.35	2.12	27.50	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	154.86	113.24	125.25	69.63	18.81	9.20	8.40	4.80	15.21	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	114.12	114.12	77.05	66.87	15.26	10.18	6.54	0.73	25.44	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	121.88	88.15	70.52	72.82	20.70	9.96	6.90	4.60	45.99	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	120.85	103.10	86.32	82.87	17.76	14.80	8.39	0.99	31.08	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	125.14	105.38	97.86	60.22	23.52	9.41	8.47	1.88	21.64	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	125.20	89.00	72.91	62.35	14.58	7.54	7.04	4.02	39.72	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	132.03	103.64	85.17	87.42	22.98	16.22	11.72	2.70	26.14	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	108.43	117.04	75.73	67.12	24.10	8.61	3.44	1.72	22.37	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	135.38	117.13	75.71	71.25	21.82	12.02	10.69	1.78	30.28	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	127.47	100.10	86.81	69.60	23.07	9.78	8.99	2.35	28.94	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	133.27	124.03	85.77	75.21	18.47	10.56	9.24	5.94	23.09	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	129.21	96.52	72.13	71.61	17.64	14.53	5.19	1.56	36.32	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	161.46	126.02	101.52	82.70	25.82	17.07	7.44	1.75	24.50	3.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	167.73	145.93	123.56	83.31	22.92	9.50	9.50	2.80	20.13	6.71
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	111.29	92.74	92.74	75.96	15.46	9.72	4.42	2.65	30.47	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	138.47	118.03	99.90	73.29	28.93	15.43	10.03	4.24	21.99	6.17
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	169.12	139.25	108.36	75.95	37.98	14.18	8.10	2.53	22.28	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	132.65	116.31	89.40	60.56	15.86	10.57	6.73	1.92	32.68	6.73
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	144.31	114.49	108.93	81.50	21.47	13.91	7.16	1.59	26.24	5.17
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	149.47	120.92	82.64	65.62	26.13	9.72	9.72	2.43	23.09	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	80.24	105.14	42.89	52.57	20.06	4.84	5.53	2.77	15.91	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	160.36	121.22	114.00	76.76	23.56	11.40	10.64	4.56	26.98	4.94
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	176.61	148.21	98.64	77.98	25.30	7.75	10.33	3.61	17.56	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	88.88	96.14	57.44	52.60	16.93	7.86	6.65	3.02	21.16	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	176.83	125.18	124.86	70.67	18.06	9.82	7.29	2.85	28.52	4.75
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	138.60	87.43	105.55	75.17	21.32	11.19	6.93	4.80	18.66	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	93.10	98.27	51.72	65.51	20.69	9.77	8.05	2.30	17.81	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	139.87	120.85	114.67	69.42	23.14	10.28	3.60	2.57	30.85	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	170.47	141.47	144.30	65.08	16.27	12.03	6.37	2.83	18.39	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	87.39	110.66	45.40	69.23	21.56	5.67	10.21	2.84	22.13	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	149.77	107.33	101.09	74.05	26.21	9.98	9.57	2.91	26.63	3.74
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	171.49	137.82	105.71	93.96	26.62	9.40	7.83	5.48	11.75	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	98.96	102.72	67.23	64.30	21.71	10.44	9.19	5.43	16.70	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	148.68	110.12	105.47	68.30	26.48	15.80	8.83	0.46	23.70	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	161.24	132.47	111.73	71.59	27.43	7.36	8.70	1.34	10.70	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	133.13	121.90	65.76	57.74	26.73	10.16	12.83	4.28	13.90	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	170.93	131.33	136.58	74.35	27.48	10.51	7.27	4.04	22.23	6.06
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	167.95	136.75	130.32	59.65	19.27	4.59	14.68	3.67	30.29	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	130.70	104.91	63.13	48.90	26.67	16.00	8.00	4.45	17.78	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	182.93	122.52	123.66	60.98	29.63	12.54	8.55	3.99	27.92	6.27
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	236.20	141.88	141.88	67.49	23.01	13.80	8.44	3.07	19.17	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	141.72	159.78	91.93	61.28	27.36	12.59	10.40	2.74	10.94	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	178.62	138.09	127.84	57.91	28.51	10.69	7.57	3.56	23.61	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	377.71	230.58	202.25	86.57	35.09	15.08	11.18	3.38	11.70	7.54
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	145.22	127.98	78.91	42.44	29.84	7.96	9.95	3.98	17.24	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	145.50	118.48	137.19	56.12	31.18	2.08	2.08	0.00	24.94	2.08
Macrophage - monocyte derived, donor1	11232-116C8	100.74	53.10	69.74	25.30	17.78	2.51	3.19	3.87	0.46	2.05
Macrophage - monocyte derived, donor2	11313-117C8	131.39	51.75	105.33	25.51	134.51	8.99	24.59	5.32	20.74	2.75
Macrophage - monocyte derived, donor3	11389-118C3	93.85	38.67	69.21	22.02	48.11	5.51	9.70	2.23	11.80	1.84
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	252.24	126.38	126.38	35.05	21.77	3.19	7.97	2.66	19.12	5.31
Mallassez-derived cells, donor2	11929-125I3	340.67	228.49	168.43	42.15	47.54	14.10	10.14	1.74	43.26	5.86
Mallassez-derived cells, donor3	11930-125I4	282.84	204.03	152.47	66.16	40.45	13.06	8.48	3.75	40.86	4.59
Mammary Epithelial Cell, donor1	11273-116H4	278.40	139.10	156.04	117.88	42.25	9.47	7.97	3.59	4.68	7.57
Mammary Epithelial Cell, donor2	11350-117G9	219.48	116.11	104.53	82.23	29.82	7.24	3.76	1.74	5.21	2.61
Mammary Epithelial Cell, donor3	11422-118F9	104.01	36.92	55.12	36.17	11.47	1.50	1.75	0.50	2.24	1.00
Mast cell - stimulated, donor1	11487-119E2	405.41	338.29	233.21	143.72	164.74	29.15	31.86	31.19	4.07	31.86
Mast cell, donor1	11563-120D6	93.22	125.98	71.05	115.28	20.55	5.62	7.89	21.52	1.41	1.95
Mast cell, donor2	11565-120D8	201.48	175.63	149.18	72.51	31.50	6.54	9.21	42.50	9.51	0.89
Mast cell, donor3	11566-120D9	170.64	158.94	137.55	76.54	35.57	8.10	10.81	54.03	5.18	1.80
Mast cell, donor4	11567-120E1	169.84	154.77	150.16	79.78	30.49	6.74	8.86	46.63	8.69	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	84.72	78.73	90.71	134.18	27.06	6.21	6.99	18.52	1.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	54.87	89.30	62.45	50.78	65.37	12.84	18.09	16.34	4.67	5.84
Mast cell, expanded, donor5	11939-126A4	75.26	86.96	81.68	92.47	19.62	2.75	6.31	19.85	0.46	0.69
Mast cell, expanded, donor8	11941-126A6	43.35	78.83	45.52	86.03	16.74	4.35	6.36	16.07	1.67	1.00
Melanocyte - dark, donor1	11502-119F8	122.28	83.28	66.46	32.34	30.84	8.16	6.07	6.27	5.87	2.59
Melanocyte - dark, donor2	11582-120F7	55.72	55.03	29.07	4.15	15.92	5.19	8.31	4.15	2.08	2.08
Melanocyte - dark, donor3	11663-122F7	220.58	131.84	72.37	25.72	49.98	5.94	10.29	2.03	5.29	1.67
Melanocyte - light, donor1	11274-116H5	118.24	91.44	43.49	10.58	26.56	2.59	5.41	0.24	7.29	0.71
Melanocyte - light, donor2	11351-117H1	68.93	43.68	21.16	8.87	21.16	2.73	2.05	0.00	4.78	0.68
Melanocyte - light, donor3	11423-118G1	51.17	28.62	37.29	12.14	11.27	1.73	0.87	0.87	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	102.88	63.93	63.83	18.85	44.25	5.73	6.25	0.52	2.81	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	85.25	72.08	46.53	20.98	29.31	4.03	4.03	0.81	2.96	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	116.25	113.03	45.80	17.68	33.75	6.43	5.09	1.07	5.89	1.34
Meningeal Cells, donor1	11493-119E8	144.16	136.47	50.86	6.58	30.64	4.22	4.59	3.35	2.36	2.11
Meningeal Cells, donor2	11573-120E7	79.23	58.54	28.17	5.28	20.25	6.60	5.28	1.32	3.08	3.08
Meningeal Cells, donor3	11654-122E7	236.03	202.94	121.60	9.45	52.73	11.17	10.43	4.08	1.71	3.67
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	156.55	88.68	90.68	11.98	37.64	7.98	6.84	2.00	1.43	7.41
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	87.85	100.53	32.50	6.34	21.23	5.43	4.33	3.02	1.31	2.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	7.88	0.00	0.00	0.00	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	27.47	18.31	9.16	1.31	3.92	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	108.36	83.96	43.06	2.15	17.22	5.74	6.46	0.00	0.00	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	72.21	114.57	33.25	3.81	13.55	6.56	4.45	3.39	2.12	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	72.38	88.97	38.20	3.02	16.59	7.54	4.52	1.51	4.02	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	67.90	55.82	38.90	1.98	8.13	0.66	1.98	1.32	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	76.71	21.92	41.64	2.19	10.96	2.92	2.92	1.46	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	51.56	26.80	27.01	1.43	5.12	0.61	0.61	1.23	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	44.32	104.16	41.28	3.74	14.13	1.52	3.46	2.63	0.14	4.02
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	17.10	21.93	10.78	0.37	3.72	0.37	1.12	1.49	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	136.18	132.23	62.50	9.21	18.82	6.84	5.79	3.29	0.92	3.16
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.29	20.77	9.50	3.56	3.26	0.00	0.30	0.30	0.00	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	4.67	4.67	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	54.43	41.63	28.82	7.68	10.89	2.56	1.28	1.28	2.56	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	170.49	171.20	78.33	6.73	19.85	5.67	6.38	5.32	0.71	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	105.08	123.53	52.22	6.57	15.01	7.19	5.63	3.13	0.94	3.13
Mesenchymal stem cells - umbilical, donor0	11214-116A8	76.20	68.22	33.38	9.43	15.24	3.63	4.35	2.18	5.08	2.18
Mesothelial Cells, donor1	11247-116E5	105.01	128.34	47.73	15.91	15.91	4.51	4.77	3.18	5.83	3.45
Mesothelial Cells, donor2	12156-128G5	116.11	128.12	50.55	10.51	17.02	3.50	3.00	3.00	3.00	6.01
Mesothelial Cells, donor3	11402-118D7	103.56	70.39	44.37	17.85	13.44	2.53	2.60	2.17	6.65	2.75
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	97.22	36.46	62.11	4.05	54.01	10.80	14.85	1.35	31.06	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	77.08	36.20	65.76	13.55	59.60	8.62	15.76	3.20	23.64	3.69
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	67.73	37.69	71.55	15.90	90.40	10.01	18.55	4.12	27.68	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	17.29	44.94	0.00	31.11	3.46	6.91	3.46	10.37	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	64.78	34.40	44.32	11.16	53.00	7.75	10.23	2.79	13.33	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	69.70	29.46	60.57	13.90	68.45	6.85	16.39	2.07	17.01	2.70
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	6.95	27.79	2.32	32.42	0.00	2.32	0.00	16.21	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	69.57	37.04	59.56	13.76	60.81	6.76	17.02	2.75	17.77	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	72.15	30.72	60.51	12.57	72.15	5.59	20.48	1.40	23.74	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	19.47	38.93	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	72.14	34.95	52.63	9.14	58.32	7.11	12.80	4.06	13.01	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	70.09	22.17	70.09	12.27	59.00	7.52	14.65	1.58	20.99	3.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	25.65	0.00	0.00	0.00	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	48.67	37.17	37.17	11.50	59.29	4.42	9.73	1.77	8.85	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	66.11	39.51	54.71	18.62	88.91	9.50	13.68	3.04	17.86	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	42.11	6.58	44.74	2.63	18.42	2.63	3.95	0.00	7.90	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	58.79	36.50	48.81	8.91	47.75	4.88	7.64	2.33	13.58	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	11.05	35.91	9.21	35.91	2.76	8.29	0.92	18.42	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	58.72	22.65	38.75	6.56	36.06	4.47	6.56	2.98	14.31	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	3.35	25.15	1.68	20.12	5.03	8.38	1.68	21.80	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	52.19	30.11	50.68	7.53	43.91	6.27	10.79	2.26	10.29	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	59.42	29.00	55.14	9.51	57.99	6.65	14.50	2.14	18.78	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	49.21	12.72	38.15	6.08	16.59	1.11	3.87	0.55	7.74	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	64.93	38.22	49.27	9.21	50.88	5.53	10.59	2.76	17.27	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	65.42	28.82	54.90	9.89	64.15	8.62	12.41	2.10	14.93	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	74.60	26.50	45.66	8.36	44.43	6.73	9.38	1.63	7.34	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	69.73	45.27	46.55	10.08	48.91	6.65	11.37	4.29	7.94	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	52.68	22.67	50.24	10.00	51.57	6.22	13.78	1.33	21.12	2.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	20.64	0.00	0.00	20.64	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	64.61	35.48	36.58	5.04	39.20	4.38	5.91	2.85	8.76	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	47.15	18.25	35.99	8.62	35.99	3.55	9.63	1.52	13.69	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	8.28	26.51	3.31	9.94	1.66	4.97	0.00	6.63	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	70.12	35.60	48.92	4.89	36.42	5.98	9.78	2.72	11.69	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	57.35	28.82	51.46	11.76	57.05	5.88	12.65	2.94	13.53	2.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	10.90	27.26	3.27	19.63	2.18	6.54	1.09	5.45	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	70.16	25.95	33.16	6.73	42.77	5.29	7.21	1.92	12.01	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	55.63	26.42	44.43	8.40	48.83	4.80	13.61	1.20	11.21	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	15.08	24.68	8.23	16.45	2.74	9.60	0.00	9.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	62.07	36.54	43.05	8.01	35.54	4.00	5.01	4.00	9.51	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	53.89	26.95	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	12.23	12.23	4.08	14.27	2.04	2.04	0.00	14.27	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	63.94	38.54	36.79	6.13	44.67	4.82	5.69	3.07	7.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	8.83	29.80	4.41	25.38	1.10	1.10	2.21	22.07	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	51.23	21.13	23.69	7.68	17.29	3.84	7.04	0.64	10.89	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	62.72	50.58	47.85	10.16	45.62	4.96	10.16	2.48	9.92	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	28.53	11.13	32.71	6.26	22.27	4.87	9.74	1.39	20.88	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	11.05	19.89	8.84	28.73	2.21	6.63	2.21	13.26	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	73.16	51.62	44.79	14.70	38.29	5.81	6.50	3.08	4.79	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	44.20	14.00	25.38	10.50	25.82	3.94	5.69	2.63	11.38	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.93	15.98	23.08	14.56	13.85	2.13	2.49	1.07	4.97	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	67.05	57.23	44.61	16.55	40.40	4.77	7.29	3.09	7.57	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	39.48	22.03	39.07	11.64	34.50	4.99	9.56	2.08	12.88	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	40.21	18.07	33.80	12.82	14.57	1.75	3.50	1.17	4.66	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	57.01	39.22	44.65	15.08	24.74	3.92	6.03	1.51	5.43	2.71
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	50.50	33.39	44.66	15.03	37.98	9.60	7.93	4.17	7.10	3.34
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	28.88	57.75	7.22	0.00	0.00	0.00	0.00	14.44	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	60.03	26.78	34.17	12.01	16.62	9.24	3.69	1.85	3.69	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	59.76	39.27	54.64	18.78	52.36	6.83	11.95	5.12	15.37	3.98
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	49.05	26.67	34.82	20.73	21.56	3.32	4.84	1.80	2.07	2.49
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	61.94	42.24	44.83	19.70	36.02	3.11	3.89	2.07	3.11	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	49.76	17.59	47.19	13.30	38.18	4.29	8.58	1.29	12.87	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	43.83	17.15	31.12	8.26	5.72	1.91	2.54	0.00	1.91	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	48.57	29.09	40.83	17.08	24.55	2.94	2.40	1.07	3.20	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	61.36	42.80	64.06	22.75	46.70	5.39	8.08	2.99	9.28	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	40.54	22.46	32.21	18.50	15.82	1.41	3.81	1.41	1.70	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	49.69	48.10	50.96	18.79	29.30	2.87	7.01	2.55	2.23	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	64.35	26.76	57.05	19.68	53.73	5.31	7.96	2.87	8.40	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	61.43	17.44	32.99	15.93	16.31	1.14	3.41	0.76	1.52	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	54.83	44.04	49.72	19.04	36.65	5.40	7.67	1.99	3.13	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	52.36	35.15	50.39	24.33	47.19	4.67	8.11	2.46	7.37	3.44
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	30.63	11.73	28.02	11.73	9.78	3.26	1.30	0.65	0.00	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	64.39	40.87	52.34	25.29	26.76	4.41	4.70	1.18	2.06	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	53.92	35.75	57.95	25.66	42.67	4.32	4.61	2.59	5.19	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	97.27	61.82	83.25	35.44	29.67	4.53	5.77	1.24	2.47	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	60.45	35.44	61.05	17.57	22.33	3.57	6.25	2.68	2.38	2.38
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	18.83	30.14	11.30	22.60	3.77	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	64.16	26.73	28.52	23.17	10.69	0.00	3.56	3.56	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	67.69	40.09	39.43	19.71	7.89	2.96	4.93	1.31	0.33	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	62.07	33.66	52.60	22.09	46.29	8.42	8.42	0.00	13.68	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	90.15	35.58	67.02	15.42	26.89	4.74	5.93	3.16	3.36	1.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	95.93	19.56	87.54	29.80	41.91	10.24	9.31	4.66	10.24	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	67.60	40.18	40.18	16.52	24.03	3.38	5.63	3.38	2.63	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	67.38	31.16	59.39	12.78	66.59	5.86	13.58	3.20	22.11	2.40
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	112.76	58.36	73.97	25.56	18.44	2.94	2.94	2.71	1.24	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	47.15	22.84	40.52	12.52	19.89	2.21	3.68	4.42	3.68	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.50	28.21	43.97	17.22	11.36	1.47	3.30	2.93	0.37	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	28.00	70.00	18.67	49.78	4.67	6.22	1.56	7.78	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	148.57	83.91	100.47	41.15	36.34	4.81	9.62	3.21	0.00	5.34
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	15.46	11.59	15.46	11.59	0.00	0.00	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	59.59	24.24	35.35	14.14	14.14	2.02	4.04	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	68.73	49.75	56.92	26.56	52.28	8.43	10.12	3.37	11.81	2.11
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	115.77	73.54	66.74	29.96	34.05	1.36	5.45	0.00	2.72	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	146.23	83.92	79.47	24.16	50.86	6.36	5.72	5.09	5.72	5.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	158.73	102.04	88.27	38.87	36.44	6.48	9.72	2.43	2.43	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	36.25	30.21	51.35	16.61	37.76	3.02	3.02	0.00	18.13	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	34.26	17.13	11.42	0.00	5.71	5.71	5.71	5.71	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	101.14	58.72	78.30	29.36	65.25	6.52	3.26	9.79	81.56	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	85.54	47.52	95.05	14.26	38.02	4.75	0.00	9.50	23.76	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	25.10	12.55	0.00	12.55	0.00	0.00	0.00	75.29	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	140.68	143.70	65.28	4.96	17.02	4.31	4.96	2.37	1.08	4.52
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	61.15	61.15	33.45	9.41	9.41	6.79	3.66	1.57	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	41.38	33.37	21.36	2.67	8.01	6.01	3.34	1.33	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	39.23	24.62	25.88	1.25	7.51	3.34	3.34	0.00	1.67	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	57.23	82.90	29.85	5.32	13.69	6.27	3.04	2.09	0.95	7.23
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	122.88	70.22	62.24	1.60	17.55	4.79	11.17	1.60	1.60	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.00	14.96	10.20	0.68	4.08	2.72	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	294.02	299.54	141.50	16.54	69.83	20.21	9.19	20.21	3.68	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.23	20.09	9.63	1.67	5.02	2.93	2.09	1.26	0.42	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	41.84	30.45	15.81	2.09	9.07	3.02	2.56	0.93	1.63	4.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.38	20.81	13.78	1.89	6.22	1.62	1.08	0.00	1.35	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.67	38.26	28.17	3.57	9.25	2.73	3.78	0.84	0.21	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	367.45	701.49	133.62	22.27	89.08	33.40	33.40	33.40	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	53.11	48.64	26.80	3.47	15.39	4.96	4.96	0.99	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.32	28.96	10.29	2.17	7.04	1.62	0.81	0.54	0.00	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.53	24.48	12.92	2.04	7.93	2.04	1.36	0.45	1.13	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.15	20.09	14.70	0.65	4.25	0.82	1.14	0.16	0.16	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.20	45.38	23.88	2.73	9.11	1.09	2.55	0.18	0.36	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	25.46	13.79	1.59	4.24	0.53	2.65	1.06	0.00	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.01	16.81	15.01	1.80	4.20	3.00	2.40	0.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	34.46	80.08	17.07	2.63	10.83	4.27	3.28	2.30	0.33	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.15	16.75	6.99	1.63	3.25	1.63	0.81	0.16	0.81	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	52.03	47.09	25.40	2.47	7.06	2.12	3.17	0.53	0.35	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	26.02	5.63	1.41	4.92	0.70	0.70	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.99	14.71	15.63	0.46	6.44	0.92	1.38	0.46	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	26.67	8.35	0.96	6.43	2.57	0.96	0.00	0.64	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	39.66	84.50	20.35	3.45	5.86	3.79	2.76	2.76	1.03	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	285.71	257.90	93.55	2.53	22.76	17.70	7.59	7.59	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	36.98	26.29	17.60	1.11	3.34	0.67	1.56	0.22	0.00	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.48	20.75	7.20	0.85	2.12	1.27	0.42	0.85	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.17	25.40	8.54	1.19	4.98	1.66	0.71	0.71	0.24	2.14
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	15.88	14.17	1.29	6.44	2.58	0.43	0.43	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	478.47	586.80	117.36	9.03	72.22	45.14	9.03	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.66	19.99	12.33	1.00	2.67	0.33	1.00	0.33	0.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	17.58	20.29	0.90	5.41	1.35	0.45	2.25	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.22	23.41	9.52	1.59	4.76	0.40	1.19	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	20.43	16.72	0.93	6.50	1.86	0.00	0.93	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.89	19.68	14.76	1.51	3.78	0.76	0.00	0.38	1.14	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.29	17.60	10.75	1.96	4.24	0.65	0.65	0.33	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.56	9.59	7.84	0.44	3.49	1.31	1.74	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	40.25	35.28	19.45	0.90	4.98	2.71	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	16.76	11.46	1.76	8.82	0.00	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	22.60	18.62	9.31	0.66	5.98	0.66	0.66	0.66	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.85	15.87	19.35	0.99	6.94	1.49	2.98	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	14.16	10.72	1.91	3.45	1.15	1.53	0.38	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.13	23.29	18.15	0.91	4.84	2.12	1.51	0.30	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.68	34.92	25.20	2.43	8.40	3.09	2.21	1.55	0.22	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	14.91	10.84	1.36	2.03	0.00	1.36	0.00	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	163.50	224.82	76.64	0.00	15.33	0.00	5.11	0.00	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.66	22.56	12.19	1.22	4.27	0.61	1.83	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.25	9.76	5.98	0.63	2.20	0.31	0.94	0.00	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.11	10.90	4.24	1.21	4.54	1.21	0.61	0.00	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	30.06	14.24	0.79	3.96	1.58	0.00	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	68.02	79.36	32.88	1.13	5.67	5.67	2.27	4.53	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	252.89	232.66	50.58	5.06	15.17	15.17	10.12	0.00	0.00	10.12
Myoblast, donor1	11241-116D8	143.86	130.07	62.24	4.60	13.54	2.98	2.61	3.23	1.12	3.23
Myoblast, donor2	11322-117D8	77.48	66.93	43.73	5.18	9.40	2.49	1.92	1.73	0.96	1.34
Myoblast, donor3	11398-118D3	112.16	85.43	72.31	6.56	18.16	3.53	5.55	3.36	1.35	4.20
NK T cell leukemia cell line:KHYG-1	10777-110G3	238.60	151.19	41.30	208.10	23.93	6.71	7.73	2.63	7.44	3.06
Natural Killer Cells, donor1	11230-116C6	287.22	405.00	90.72	192.20	11.07	2.15	4.31	31.98	4.00	2.77
Natural Killer Cells, donor2	11311-117C6	242.75	234.61	71.47	129.37	7.54	1.51	2.11	23.22	3.62	1.21
Natural Killer Cells, donor3	11387-118C1	238.72	254.73	67.36	130.13	4.60	2.58	1.84	25.40	4.79	1.84
Neural stem cells, donor1	11275-116H6	207.60	255.51	165.14	14.88	122.31	18.51	28.31	7.98	2.54	5.08
Neural stem cells, donor2	11352-117H2	273.44	292.70	182.94	55.84	256.11	30.81	48.14	1.93	1.93	9.63
Neurons, donor1	11494-119E9	229.86	152.48	133.13	27.31	192.30	17.07	28.45	1.14	3.41	3.41
Neurons, donor2	11574-120E8	320.56	177.01	157.86	76.18	165.12	19.59	28.40	6.38	4.18	3.30
Neurons, donor3	11655-122E8	197.32	127.44	99.48	21.38	141.41	20.55	22.20	1.64	6.58	4.11
Neutrophils, donor1	11233-116C9	348.00	486.27	103.94	385.12	5.57	1.86	0.93	55.68	1.86	8.35
Neutrophils, donor2	11314-117C9	229.01	217.42	95.66	272.49	2.90	0.00	2.90	31.89	0.00	2.90
Neutrophils, donor3	11390-118C4	514.94	658.49	172.26	653.60	15.88	2.44	3.05	91.63	2.44	17.10
Nucleus Pulposus Cell, donor1	11252-116F1	116.95	58.54	90.36	12.11	24.93	5.34	5.11	1.19	0.36	2.97
Nucleus Pulposus Cell, donor2	11409-118E5	35.17	26.05	33.86	7.16	8.47	1.95	2.60	0.98	0.65	3.26
Nucleus Pulposus Cell, donor3	11462-119B4	42.12	32.29	31.69	6.02	11.03	2.01	2.01	1.00	0.80	2.01
Olfactory epithelial cells, donor1	11933-125I7	49.83	46.94	24.50	2.34	10.74	4.13	3.99	1.51	1.51	2.06
Olfactory epithelial cells, donor2	11934-125I8	78.16	76.43	32.57	4.20	13.32	8.54	5.07	1.74	2.17	1.59
Olfactory epithelial cells, donor3	11935-125I9	59.59	42.79	32.58	3.86	12.03	5.45	3.41	0.68	3.18	1.25
Olfactory epithelial cells, donor4	11936-126A1	74.90	46.26	36.91	2.73	8.18	4.19	3.12	0.97	1.07	1.07
Oligodendrocyte - precursors, donor1	11496-119F2	185.36	119.76	90.27	80.04	31.29	4.81	6.62	3.01	9.63	6.62
Osteoblast - differentiated, donor1	11276-116H7	54.24	61.04	29.56	2.34	9.78	2.34	1.91	2.77	0.43	2.55
Osteoblast - differentiated, donor2	11353-117H3	16.00	32.01	11.43	2.29	3.43	1.14	0.00	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	26.07	27.93	26.07	4.34	1.86	0.62	1.86	0.62	0.62	1.24
Osteoblast, donor1	11277-116H8	85.41	65.08	42.02	3.13	14.46	1.76	3.71	0.20	0.59	2.93
Osteoblast, donor2	11354-117H4	172.77	132.04	100.43	3.51	35.82	4.92	5.62	4.21	2.11	4.92
Osteoblast, donor3	11426-118G4	144.32	60.78	63.98	4.62	17.24	4.27	4.09	2.49	0.53	4.98
Pancreatic stromal cells, donor1	11249-116E7	142.86	137.14	68.99	5.98	20.64	6.49	8.42	2.78	1.01	3.96
Pericytes, donor1	11491-119E6	23.25	21.70	7.68	2.45	5.56	0.89	1.11	0.33	0.78	0.78
Pericytes, donor2	11571-120E5	17.66	12.90	10.41	0.45	3.85	0.23	1.58	0.00	0.68	0.68
Pericytes, donor3	11652-122E5	63.48	31.94	30.31	2.24	4.68	0.61	2.03	0.61	1.42	1.22
Perineurial Cells, donor1	11499-119F5	142.86	109.29	71.43	10.62	28.03	3.96	4.86	4.52	1.24	3.96
Perineurial Cells, donor2	11579-120F4	89.43	99.00	44.90	10.58	25.95	11.87	8.37	5.43	1.75	3.22
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	221.84	272.84	95.94	208.46	5.42	0.64	2.23	24.86	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	144.22	145.69	52.40	96.97	4.65	1.22	0.49	13.22	2.94	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	168.63	149.22	59.66	107.80	4.53	1.42	1.42	13.20	1.55	0.91
Placental Epithelial Cells, donor1	11278-116H9	61.70	59.79	27.98	20.09	9.09	2.63	1.20	0.24	2.87	3.83
Placental Epithelial Cells, donor2	11355-117H5	57.66	45.46	38.81	11.09	19.96	3.33	2.22	0.00	4.44	4.44
Placental Epithelial Cells, donor3	11427-118G5	79.12	32.20	29.45	9.42	18.06	3.14	4.12	0.39	6.28	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	57.59	65.51	27.21	5.70	9.81	3.80	1.27	0.95	3.16	1.27
Preadipocyte - breast, donor1	11467-119B9	93.61	123.06	47.46	7.13	11.63	2.63	2.44	3.38	0.19	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	143.84	109.77	64.87	5.22	13.97	2.74	4.70	1.96	0.13	1.44
Preadipocyte - breast, donor2	11328-117E5	89.83	65.52	49.31	7.20	11.48	3.83	2.48	2.03	1.58	4.28
Preadipocyte - omental, donor1	11468-119C1	96.76	126.06	43.05	6.07	11.19	3.20	2.02	4.58	0.53	3.30
Preadipocyte - omental, donor2	11329-117E6	110.86	153.64	51.07	10.04	15.28	7.42	5.67	4.80	1.75	3.49
Preadipocyte - omental, donor3	11403-118D8	93.54	79.50	45.55	3.87	11.17	3.72	3.87	4.01	1.86	5.73
Preadipocyte - perirenal, donor1	11469-119C2	41.34	33.47	8.86	1.97	4.92	1.97	0.00	2.95	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	90.60	82.31	35.93	1.54	14.43	1.84	4.30	2.15	0.61	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	152.11	120.94	81.99	4.07	26.38	8.68	8.68	7.08	0.89	6.55
Preadipocyte - subcutaneous, donor3	11428-118G6	91.44	87.87	44.27	2.21	19.07	6.64	4.77	2.72	2.21	2.04
Preadipocyte - visceral, donor1	11280-116I2	171.95	188.72	87.65	9.04	33.16	8.10	8.10	5.96	1.21	5.87
Preadipocyte - visceral, donor2	11357-117H7	113.20	115.51	78.69	7.82	32.21	4.60	8.28	4.14	0.92	4.60
Preadipocyte - visceral, donor3	11429-118G7	83.59	80.35	37.20	4.49	20.17	5.02	5.43	3.03	0.63	4.28
Prostate Epithelial Cells (polarized), donor1	11253-116F2	100.17	63.81	45.56	79.20	9.50	5.13	2.87	0.75	1.96	5.58
Prostate Epithelial Cells, donor2	11331-117E8	149.36	81.79	77.19	28.57	14.90	2.98	2.17	1.08	8.40	3.66
Prostate Epithelial Cells, donor3	11404-118D9	230.86	52.17	116.84	145.81	8.39	2.45	1.41	1.22	3.92	1.96
Prostate Stromal Cells, donor1	11254-116F3	186.11	141.58	73.81	7.40	20.50	8.54	6.15	3.42	2.39	4.78
Prostate Stromal Cells, donor2	11332-117E9	108.12	83.37	46.62	2.69	18.65	4.66	3.05	2.51	0.72	2.69
Prostate Stromal Cells, donor3	11405-118E1	62.67	71.12	28.26	2.71	9.91	3.44	2.61	1.15	1.25	3.02
Renal Cortical Epithelial Cells, donor1	11516-119H4	79.93	38.32	51.83	23.72	12.41	2.92	2.19	0.73	1.82	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	268.72	129.47	129.41	84.08	47.06	11.09	8.80	2.70	6.58	4.92
Renal Epithelial Cells, donor1	11517-119H5	53.77	21.30	22.32	8.62	7.10	1.52	0.00	0.00	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	68.29	19.92	34.14	13.52	11.38	3.56	1.42	1.42	4.98	0.00
Renal Epithelial Cells, donor3	11678-122H4	279.69	152.87	157.63	78.98	55.16	15.03	8.68	4.34	3.18	5.72
Renal Glomerular Endothelial Cells, donor1	11514-119H2	35.40	12.94	12.26	2.04	4.09	0.00	0.68	0.68	2.72	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	58.49	35.44	24.12	8.22	8.22	0.81	1.89	1.08	2.43	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	117.00	71.71	72.82	7.10	25.98	5.77	4.44	3.77	3.77	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	3.99	5.99	1.33	1.33	0.00	0.67	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	78.57	38.08	38.08	10.12	12.32	2.20	1.10	1.32	3.08	2.86
Renal Mesangial Cells, donor2	11598-120H5	70.85	19.44	33.23	18.18	10.03	2.51	0.63	0.63	3.76	1.88
Renal Mesangial Cells, donor3	11679-122H5	29.13	9.15	16.09	8.04	6.66	0.83	0.83	0.28	3.05	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	187.90	85.36	105.49	43.75	16.37	2.68	2.95	2.42	4.29	1.88
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	75.06	26.99	43.01	28.68	6.75	3.37	1.27	0.42	2.53	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	111.27	37.80	51.88	18.51	16.01	3.09	3.66	0.96	4.05	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	176.05	149.09	78.82	32.67	37.08	8.82	11.41	2.07	8.82	3.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	75.32	70.78	23.02	14.50	20.75	4.55	2.27	1.42	11.09	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	47.34	32.93	17.50	2.06	4.12	0.00	3.09	1.03	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	134.99	111.15	64.23	48.68	22.33	5.52	5.27	2.01	0.75	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	84.46	53.72	48.51	50.25	6.82	1.60	2.81	5.48	2.14	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.10	25.91	42.88	14.29	5.36	0.89	0.00	0.89	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	55.59	73.75	58.34	42.38	22.01	4.40	2.20	2.20	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	40.02	51.04	53.95	33.06	9.28	4.06	1.16	1.16	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	122.74	42.26	79.97	33.42	14.56	2.73	1.17	0.39	0.78	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	109.24	18.87	88.48	25.72	8.54	2.58	1.49	0.99	0.30	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	163.85	41.72	132.73	41.16	14.83	1.78	2.90	0.67	0.33	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	138.31	43.17	134.96	39.57	15.13	3.97	2.48	1.61	0.62	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	108.62	23.19	93.35	29.49	8.97	2.45	2.10	0.70	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	126.89	34.67	102.16	39.06	10.40	1.62	1.85	1.39	0.92	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	79.95	21.91	55.72	21.63	7.26	1.51	0.96	0.96	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	121.32	24.66	90.31	34.94	11.35	2.72	1.97	1.21	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	149.44	32.61	127.76	32.08	10.57	1.43	0.90	0.72	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	80.91	20.08	51.64	20.80	9.18	1.58	1.15	1.15	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	115.36	22.00	92.72	28.33	9.23	1.93	1.72	0.64	1.07	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	89.17	20.80	86.74	30.31	9.07	1.77	1.11	0.89	0.66	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	79.34	22.18	48.56	15.87	10.13	1.34	1.53	0.57	0.38	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	126.52	21.99	92.51	29.25	7.92	1.86	1.30	0.93	0.84	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	152.20	53.37	141.31	41.53	14.47	2.63	2.82	1.32	0.38	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	87.45	21.50	59.98	23.22	8.76	1.99	2.12	0.93	0.93	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	118.56	24.53	88.00	28.42	9.73	2.24	1.07	0.58	0.29	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	109.99	23.68	92.42	31.70	8.02	1.91	0.57	0.38	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	91.84	24.14	63.76	22.75	8.54	2.24	1.39	0.53	0.53	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	110.44	25.23	93.34	26.35	8.41	1.68	3.36	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	106.98	23.75	95.02	30.08	8.72	2.56	2.73	0.68	0.68	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	85.70	18.42	63.09	20.42	7.11	0.73	2.19	0.55	0.73	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	104.85	22.56	86.09	21.22	9.93	2.33	2.58	0.74	0.49	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	118.20	22.43	89.99	32.37	7.25	2.42	1.75	1.21	0.13	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	99.07	24.53	54.96	21.23	9.91	1.89	2.12	1.42	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	108.73	27.18	88.10	26.39	9.92	1.19	2.18	0.60	0.60	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	113.42	30.63	75.77	24.55	10.76	2.81	1.64	0.47	0.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	82.53	23.85	57.02	20.94	11.82	0.62	1.87	0.83	1.04	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	132.73	29.42	106.40	28.98	11.28	3.76	1.33	0.66	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	107.78	24.65	83.76	26.32	8.98	1.67	2.09	0.84	0.84	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	95.42	23.42	64.60	19.65	10.50	2.56	1.21	0.94	0.40	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	114.78	22.14	88.55	26.23	10.56	2.04	1.19	0.68	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	112.59	27.57	90.42	22.56	13.11	1.74	1.74	0.58	0.58	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	102.82	27.85	72.21	25.79	18.91	2.92	2.24	1.03	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	127.98	22.77	93.14	29.63	10.84	3.02	2.19	0.82	0.55	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	121.32	35.46	96.04	35.13	11.00	3.45	2.46	0.49	0.49	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	85.04	23.86	47.55	28.46	9.54	1.70	2.05	1.53	0.85	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	142.04	28.70	105.49	48.09	16.13	2.81	2.96	0.89	0.44	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	98.09	20.26	82.36	28.25	8.80	2.13	2.40	0.53	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	56.55	24.75	45.21	22.68	6.36	0.55	1.11	1.38	0.55	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	96.91	25.00	73.34	37.62	6.19	1.90	1.19	0.71	0.95	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	99.16	23.18	92.10	33.25	8.67	2.02	1.01	0.60	0.00	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	61.68	28.44	44.45	33.15	7.63	1.51	1.51	1.32	0.38	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	101.32	27.60	83.85	48.91	9.78	0.00	3.14	0.35	0.35	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	86.74	20.85	58.63	29.31	8.16	1.21	2.12	0.91	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	68.29	32.80	45.04	37.08	10.89	1.59	1.71	1.10	1.10	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	166.80	69.43	120.23	62.30	15.57	2.04	3.49	2.47	0.73	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	99.78	35.29	60.84	43.81	7.91	3.65	3.04	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	62.39	27.13	37.37	33.15	9.34	1.21	1.81	1.21	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	82.11	31.89	51.80	44.56	7.92	1.13	0.68	1.58	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	82.67	30.85	55.71	42.53	5.69	2.10	0.60	0.90	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	63.76	57.62	43.81	44.04	10.15	1.89	1.30	2.36	1.30	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	67.45	32.44	48.03	38.85	7.90	1.92	1.71	1.49	0.21	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	84.74	38.46	49.88	28.85	8.41	2.40	0.60	3.00	0.60	3.00
Schwann Cells, donor1	11498-119F4	35.17	16.55	15.42	3.39	7.90	0.94	1.50	0.38	0.56	0.56
Schwann Cells, donor2	11578-120F3	71.45	85.06	57.84	6.80	17.01	13.61	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	69.45	63.75	63.75	5.26	25.41	2.85	4.38	1.53	2.63	3.51
Sebocyte, donor1	11220-116B5	295.25	105.72	119.96	76.69	23.01	8.76	3.83	0.55	8.76	2.74
Sebocyte, donor2	11301-117B5	132.81	51.47	73.99	36.76	10.11	2.30	3.68	2.30	5.06	2.30
Sebocyte, donor3	11378-118B1	79.97	30.50	42.87	21.64	6.60	1.03	1.65	0.41	3.71	1.44
Sertoli Cells, donor1	11255-116F4	125.90	157.38	43.07	9.94	38.10	4.97	3.31	3.31	0.00	3.31
Sertoli Cells, donor2	11333-117F1	33.89	76.26	50.84	14.12	5.65	5.65	2.82	2.82	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	100.73	61.14	81.91	16.28	14.96	2.20	2.64	2.64	0.18	2.20
Skeletal Muscle Cells, donor2	11358-117H8	18.07	9.40	4.34	2.17	5.78	0.72	0.72	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	60.19	35.11	42.64	6.69	8.36	3.34	3.34	2.51	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	72.26	80.75	40.84	10.05	22.15	5.18	4.71	1.57	1.73	3.93
Skeletal Muscle Cells, donor5	11455-119A6	63.47	76.70	31.96	6.99	21.26	3.72	3.86	2.97	1.04	0.74
Skeletal Muscle Cells, donor6	11459-119B1	87.42	89.73	49.09	5.69	20.78	3.69	2.92	2.62	0.31	2.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	112.27	152.47	62.37	20.16	40.45	9.83	10.58	2.90	1.26	6.68
Skeletal Muscle Satellite Cells, donor2	11321-117D7	84.61	70.63	50.23	12.84	19.55	6.42	7.71	2.85	1.28	4.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	139.89	101.89	67.26	8.63	31.25	4.86	4.37	3.27	0.89	5.16
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	97.99	70.01	55.94	7.08	20.73	2.53	3.45	1.52	0.84	2.70
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	65.14	26.78	39.81	8.69	8.69	2.17	0.72	0.72	0.00	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	42.79	37.70	21.05	4.13	15.27	3.85	3.16	0.69	0.83	1.51
Skin - palm, donor1	10286-104F7	37.61	56.41	42.98	45.66	13.43	10.74	5.37	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	72.51	25.08	40.80	24.79	8.65	3.17	2.31	1.01	2.74	1.87
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	83.42	37.62	42.53	17.99	5.73	5.73	2.45	0.82	7.36	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	72.83	28.95	38.04	31.55	11.94	2.21	2.60	1.95	5.45	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	301.37	133.73	150.41	106.90	20.30	7.09	4.31	3.06	4.03	3.48
Small Airway Epithelial Cells, donor2	11334-117F2	156.69	40.79	75.53	51.76	10.69	4.78	3.38	1.41	5.34	4.78
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	156.05	55.19	105.30	38.69	17.76	5.29	5.29	1.69	8.88	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	183.78	34.18	103.81	91.74	8.54	2.62	1.87	1.65	3.45	1.87
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	76.22	65.42	26.54	2.16	6.79	2.16	1.54	4.32	2.16	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.36	56.69	28.24	1.56	6.23	1.56	2.45	0.67	0.67	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	119.33	81.12	34.68	5.29	3.53	1.18	2.35	4.11	1.18	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	89.94	110.05	80.44	3.54	7.73	0.88	1.10	1.55	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	80.72	59.46	37.80	1.97	9.45	2.36	3.15	1.18	1.18	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	91.94	110.48	57.17	8.50	11.59	4.64	3.86	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	46.03	48.04	28.02	1.00	25.02	2.00	6.00	0.00	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	145.85	118.71	52.03	3.73	11.05	3.19	3.06	1.86	0.67	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	89.33	84.89	33.91	2.66	9.31	6.65	4.43	3.32	0.44	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	114.97	102.55	45.96	4.87	10.88	3.71	4.48	4.23	2.05	4.35
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	113.31	140.33	46.89	7.49	24.09	6.51	7.49	1.95	2.28	6.84
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	101.89	147.07	57.29	8.27	23.04	4.43	5.61	1.48	0.30	5.02
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	88.12	94.53	27.76	4.70	7.69	3.70	2.85	0.57	0.85	2.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	47.34	26.52	20.33	0.49	2.77	0.98	0.65	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	47.80	39.88	28.01	3.04	4.26	3.35	1.52	0.61	0.30	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	91.68	76.02	46.47	3.03	18.18	4.04	7.58	2.53	1.52	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	18.36	159.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	66.28	47.21	24.80	1.91	7.15	1.91	1.91	1.43	1.43	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	92.61	140.10	45.27	10.32	19.02	6.64	7.37	1.77	1.18	2.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	66.51	83.30	29.06	6.67	11.84	6.67	4.30	2.58	2.58	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	97.72	96.56	40.41	8.29	14.17	5.14	3.36	2.83	1.57	2.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	88.94	62.64	34.03	4.18	10.83	1.55	1.55	1.70	0.62	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	77.61	36.65	24.79	3.23	4.31	0.00	1.08	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	69.04	53.20	27.20	3.59	9.86	0.60	2.09	1.79	1.79	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	50.19	23.90	21.85	2.73	4.78	2.73	2.05	0.34	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	131.22	87.72	70.21	24.11	27.41	6.52	6.67	3.38	1.33	1.96
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	127.61	180.75	77.09	8.05	17.51	3.62	4.53	2.62	4.43	4.43
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	120.38	76.00	61.89	9.56	9.56	0.91	2.28	3.87	0.91	2.96
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	49.51	42.87	19.32	1.21	5.43	1.21	0.60	1.81	0.60	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	167.43	156.04	98.29	14.84	32.06	6.89	5.30	3.97	2.12	5.30
Smooth Muscle Cells - Prostate, donor1	11257-116F6	97.34	129.30	40.48	5.73	21.17	3.86	6.66	3.86	5.06	3.86
Smooth Muscle Cells - Prostate, donor2	11335-117F3	68.24	87.53	33.31	5.01	12.40	4.88	5.01	2.00	3.01	2.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	60.88	79.90	32.22	1.78	8.12	3.04	2.54	1.78	0.51	4.57
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	189.37	129.36	88.81	6.63	23.07	4.22	4.22	3.32	2.26	4.22
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	55.51	28.51	34.51	2.25	7.50	2.25	0.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	74.95	167.99	133.10	6.46	2.58	2.58	2.58	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	116.73	71.16	53.95	7.91	9.77	3.26	4.19	2.79	0.47	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	101.99	75.73	45.44	2.02	8.08	2.52	1.51	3.53	1.51	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	75.84	70.51	22.25	3.45	7.21	0.63	1.25	1.88	0.31	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	29.20	23.30	16.52	1.77	2.06	0.88	0.29	0.00	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	176.44	116.13	111.30	7.66	27.16	5.66	6.91	4.92	1.17	5.91
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	64.00	46.72	46.25	4.67	19.15	1.40	5.14	3.74	0.93	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	153.70	101.32	54.55	6.33	14.97	3.74	2.45	3.17	1.58	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	128.50	57.62	44.87	8.41	13.51	5.10	3.31	3.57	1.02	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	68.07	46.07	25.95	3.38	8.46	1.69	3.01	1.13	1.32	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	157.63	141.42	98.38	14.11	42.06	8.80	10.20	6.43	2.52	4.89
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	152.41	103.31	64.68	9.22	20.19	4.78	3.69	3.27	2.18	4.52
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.05	2.86	5.71	0.48	1.90	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	168.33	106.92	48.93	6.12	16.39	3.43	4.40	2.69	0.73	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	65.84	134.34	27.40	1.77	14.58	3.54	2.43	2.43	1.99	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	86.60	117.32	49.74	5.56	14.04	6.44	4.10	4.68	0.88	2.63
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	36.73	43.34	16.13	1.75	4.66	3.11	0.97	1.94	0.39	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	48.92	64.53	23.80	1.85	7.14	3.70	1.06	1.59	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.40	139.85	22.69	2.60	12.27	2.98	2.60	1.12	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	63.24	113.19	22.28	3.59	13.65	3.59	2.16	1.44	2.52	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	63.03	56.21	30.95	4.83	12.78	3.97	1.42	0.57	1.70	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	79.56	111.46	34.66	2.76	28.36	9.85	3.15	3.54	1.18	2.76
Smooth muscle cells - airway, control, donor1	11966-126D4	37.33	66.28	17.27	1.27	6.09	0.76	1.27	1.27	0.51	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	22.76	53.51	15.97	2.40	4.39	1.20	3.59	1.20	0.40	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	21.74	49.32	12.54	2.09	6.69	0.84	0.84	0.42	0.42	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	37.59	49.96	19.25	1.38	15.58	4.58	4.58	1.38	0.92	0.46
Synoviocyte, donor1	11291-117A4	163.94	155.36	73.39	4.38	22.05	7.24	7.91	4.54	1.51	2.52
Synoviocyte, donor2	11368-117I9	83.14	61.35	40.06	5.53	13.07	2.18	3.52	1.68	0.67	1.01
Synoviocyte, donor3	11440-118H9	28.82	35.97	24.58	4.24	6.26	2.01	1.34	2.46	0.89	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	108.63	41.09	36.81	3.93	9.65	2.86	1.43	1.43	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	33.69	25.77	7.93	11.89	0.00	0.00	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	42.14	25.93	18.52	3.94	5.33	3.47	2.32	0.46	3.24	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	141.94	69.53	92.90	76.06	12.19	2.94	3.23	1.51	0.86	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	90.46	33.63	39.43	29.38	5.41	1.16	1.16	1.16	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	83.04	32.07	32.07	25.77	6.30	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	88.82	64.59	52.65	54.01	8.49	2.58	1.60	7.01	1.85	2.09
Urethra, donor2	10319-105A4	21.58	32.37	25.18	23.38	8.99	5.40	3.60	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	108.12	36.66	47.82	22.58	5.31	0.80	0.80	0.00	2.39	0.27
Urothelial Cells, donor2	11600-120H7	86.52	26.84	36.45	16.02	4.01	1.20	0.80	0.40	1.20	0.40
Urothelial Cells, donor3	11681-122H7	71.97	13.29	31.86	14.44	3.44	0.46	0.46	0.23	2.06	0.46
Urothelial cells, donor0	11216-116B1	274.83	107.88	127.05	69.32	30.98	9.58	6.02	2.45	5.35	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	335.45	346.13	149.48	156.60	21.35	10.68	7.12	121.90	16.02	9.79
Whole blood (ribopure), donor090309, donation2	12180-129A2	273.06	285.92	132.95	190.14	15.73	0.00	12.87	114.37	7.15	10.01
Whole blood (ribopure), donor090309, donation3	12181-129A3	193.72	124.58	100.62	125.27	7.53	6.85	2.74	37.65	6.16	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	221.75	181.81	136.70	176.30	9.99	3.79	3.10	51.99	2.07	5.85
Whole blood (ribopure), donor090325, donation2	12177-128I8	253.91	188.83	142.35	174.89	6.97	2.91	6.39	45.32	1.16	5.23
Whole blood (ribopure), donor090612, donation1	12182-129A4	246.77	261.35	92.67	167.64	15.62	3.12	2.08	80.18	3.12	7.29
Whole blood (ribopure), donor090612, donation2	12183-129A5	258.82	293.69	115.64	170.71	18.36	0.92	3.67	115.64	9.18	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	202.66	126.89	83.07	119.59	10.95	2.74	4.56	34.69	0.91	3.65
Wilms' tumor cell line:G-401	10809-111A8	124.59	57.24	62.54	22.45	27.51	12.09	7.77	1.36	10.61	3.82
Wilms' tumor cell line:HFWT	10597-108E3	44.00	14.96	27.28	16.72	19.36	3.52	0.00	0.88	1.76	6.16
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	186.86	74.02	109.49	87.71	27.65	6.42	6.42	1.96	4.19	4.47
achilles tendon, donor2	10292-104G4	78.53	70.26	76.46	22.73	4.13	0.00	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	102.24	111.16	88.47	194.79	11.22	1.27	0.25	8.16	0.76	8.41
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	78.24	114.23	53.40	146.73	37.84	10.68	8.13	8.13	4.18	3.02
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	180.67	102.44	128.92	166.67	35.49	12.35	5.82	2.49	5.70	12.11
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	108.57	87.62	98.23	154.29	39.73	8.71	4.35	3.81	3.54	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	116.09	83.20	125.64	161.34	27.83	14.34	7.03	3.65	1.69	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	96.44	39.76	97.70	92.63	19.88	9.31	5.71	5.50	1.27	2.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	111.61	56.62	80.85	74.86	28.04	12.25	8.71	7.89	18.24	2.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	47.59	18.95	40.54	47.59	14.54	2.64	3.97	0.44	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	38.39	23.28	44.10	92.29	15.93	3.68	5.72	0.82	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	85.81	60.57	54.75	129.30	18.25	4.27	6.21	2.72	2.33	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.94	24.84	25.76	30.36	1.66	1.10	0.37	0.92	0.18	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	50.71	39.01	78.01	11.70	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	89.00	50.89	98.99	52.05	40.43	10.69	8.83	6.97	2.79	4.65
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	132.30	114.95	102.27	140.07	23.56	8.03	5.70	3.11	1.04	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	108.71	66.63	102.87	78.91	16.37	3.21	3.80	3.51	0.88	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	66.93	37.18	60.88	133.39	13.48	8.83	3.72	3.72	4.18	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	58.81	38.25	41.13	59.63	5.76	2.47	2.88	4.11	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	31.31	9.82	22.10	50.03	4.30	3.99	2.46	0.61	2.76	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	96.86	68.70	70.41	199.27	13.65	3.41	3.84	3.41	2.56	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	104.64	79.16	76.73	211.09	14.25	5.46	4.55	1.52	2.12	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	116.26	93.15	84.73	206.04	17.81	7.70	7.46	3.13	3.85	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	106.02	51.45	101.79	108.03	7.13	4.45	3.34	3.56	0.67	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	92.39	68.38	54.37	46.70	21.68	3.34	4.34	1.00	2.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	57.60	44.60	42.74	14.87	22.30	14.87	1.86	0.00	7.43	22.30
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	111.11	86.26	119.02	32.02	30.51	15.44	10.17	18.83	2.26	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	45.36	23.55	49.72	44.92	18.75	6.54	6.11	5.23	1.74	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	35.61	22.49	13.12	7.50	11.25	5.62	11.25	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	119.87	77.48	51.34	162.49	9.42	3.77	2.12	0.94	4.47	0.94
adipose tissue, adult, pool1	10010-101C1	117.12	91.68	74.15	21.41	25.28	4.19	4.96	7.45	5.27	2.64
adipose, donor1	10184-103D4	95.00	245.12	59.81	49.84	177.68	41.05	31.67	4.69	13.49	12.90
adipose, donor2	10185-103D5	25.95	36.50	32.44	22.71	61.64	11.35	10.95	0.00	12.57	4.87
adipose, donor3	10186-103D6	55.55	61.54	72.16	25.87	64.53	20.15	13.34	0.82	23.14	5.17
adipose, donor4	10187-103D7	78.01	71.07	251.36	40.74	40.74	13.00	12.13	3.47	6.93	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	64.71	30.77	69.60	30.93	39.46	9.47	9.47	1.10	3.79	1.10
adrenal gland, adult, pool1	10081-102A9	25.46	21.83	10.91	10.91	7.28	0.00	0.00	3.64	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	104.46	91.78	51.36	216.25	6.00	3.47	2.40	9.47	3.07	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	69.67	75.75	41.09	43.95	47.52	8.58	6.07	2.50	1.07	3.93
amniotic membrane cells, donor1	12235-129G3	279.84	72.80	161.37	75.35	29.44	6.72	6.96	4.17	18.55	8.81
amniotic membrane cells, donor2	12236-129G4	106.16	87.57	72.02	52.74	32.80	4.40	9.80	3.72	6.42	5.07
amniotic membrane cells, donor3	12237-129G5	159.08	57.15	131.39	89.85	30.05	3.54	6.19	4.71	12.08	6.48
amygdala - adult, donor10196	10167-103B5	217.00	141.11	232.42	13.04	98.42	21.34	27.27	1.19	14.23	1.19
amygdala, adult, donor10252	10151-102I7	199.32	84.96	138.49	13.18	44.00	9.53	11.15	0.41	3.65	1.82
amygdala, newborn, donor10223	10360-105E9	143.95	84.57	114.26	8.71	51.97	5.16	14.20	0.65	9.04	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	108.61	73.60	66.72	18.08	18.34	3.69	3.44	7.00	1.40	2.42
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	91.78	98.18	31.77	58.91	15.44	1.54	2.43	3.09	0.88	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	59.79	22.38	47.77	45.43	73.82	7.01	7.35	1.67	1.67	0.67
aorta, adult, pool1	10052-101G7	59.82	40.60	45.31	9.22	10.20	10.59	3.14	3.73	1.77	1.37
appendix, adult	10189-103D9	83.83	64.04	47.74	130.41	7.76	6.21	5.05	5.82	4.66	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.56	63.28	31.99	120.38	12.73	5.16	2.41	6.53	5.16	4.13
artery, adult	10190-103E1	33.97	21.74	25.82	8.15	8.15	4.08	4.08	1.36	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	167.76	84.89	99.67	49.11	86.92	16.66	12.02	3.33	4.35	6.23
b cell line:RPMI1788	10427-106D4	87.29	78.66	48.03	139.78	7.29	3.57	2.97	8.77	1.49	3.57
basal cell carcinoma cell line:TE 354.T	10702-109G9	173.96	154.82	65.20	1.94	11.10	4.99	3.88	4.72	0.28	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	280.33	109.95	115.90	91.79	40.59	9.63	7.74	5.95	13.00	4.56
bile duct carcinoma cell line:TFK-1	10496-107C1	128.71	56.57	48.87	122.19	2.51	1.00	0.84	0.67	0.84	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	49.77	46.42	25.17	120.24	4.47	1.12	1.68	0.00	1.12	1.68
bladder, adult, pool1	10011-101C2	102.56	76.70	65.95	31.72	10.76	14.23	5.87	4.78	1.85	1.09
blood, adult, pool1	10053-101G8	124.02	90.80	99.66	97.44	13.29	4.43	0.00	22.15	15.50	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	78.78	67.65	50.52	5.14	16.27	3.43	5.99	2.57	0.00	2.57
bone marrow, adult	10192-103E3	126.87	91.78	80.30	21.59	22.94	4.05	4.05	5.40	10.12	2.02
brain, adult, donor1	10084-102B3	111.73	74.83	72.78	26.65	34.85	9.23	9.23	3.08	2.05	1.03
brain, adult, pool1	10012-101C3	220.60	191.65	143.10	33.18	50.78	12.69	15.92	4.68	1.56	2.67
brain, fetal, pool1	10085-102B4	232.41	106.86	117.54	32.06	133.57	16.03	21.37	5.34	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	139.41	124.88	71.36	120.25	18.17	15.86	8.59	2.97	18.83	6.61
breast carcinoma cell line:MDA-MB-453	10419-106C5	184.11	190.60	92.24	270.74	24.84	19.60	10.73	1.75	14.23	1.50
breast, adult, donor1	10080-102A8	40.41	21.47	27.15	23.99	4.42	0.63	0.63	1.89	4.42	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	90.45	48.53	113.95	71.14	13.47	3.30	2.79	2.92	8.00	6.48
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	166.36	128.02	158.01	132.96	21.65	8.04	5.88	11.75	4.33	12.99
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	152.41	172.43	146.88	14.04	104.75	12.20	18.88	3.91	3.45	3.91
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	48.18	15.98	27.11	25.90	4.84	1.94	1.21	1.21	2.18	2.91
carcinoid cell line:NCI-H1770	10703-109H1	41.37	83.22	9.87	124.59	7.05	2.35	1.88	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	310.75	145.91	74.60	39.81	27.67	13.45	11.38	2.73	28.88	4.59
carcinoid cell line:SK-PN-DW	10719-109I8	43.41	45.32	36.44	41.51	28.84	5.70	6.34	1.27	1.58	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	68.41	45.52	59.62	28.21	67.88	9.32	9.58	0.53	5.59	1.86
caudate nucleus - adult, donor10196	10177-103C6	118.59	73.68	115.13	19.57	49.51	11.51	6.91	0.00	5.76	2.30
caudate nucleus, adult, donor10252	10164-103B2	199.95	66.43	132.69	27.61	42.33	11.21	8.70	0.84	4.18	1.67
caudate nucleus, adult, donor10258	10379-105H1	162.00	97.81	133.72	44.32	66.48	12.99	11.46	3.06	3.82	0.76
caudate nucleus, newborn, donor10223	10354-105E3	156.75	73.98	94.12	20.14	47.98	5.13	6.23	1.10	4.39	0.73
cerebellum - adult, donor10196	10173-103C2	84.48	101.96	61.18	90.31	23.31	11.65	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	118.07	96.29	76.65	71.31	13.02	3.20	4.70	2.99	2.78	1.92
cerebellum, adult, pool1	10083-102B2	82.79	74.16	51.40	75.20	13.11	5.86	3.45	3.45	1.03	0.69
cerebellum, newborn, donor10223	10357-105E6	54.80	67.25	34.87	73.07	14.95	1.66	3.32	1.66	0.83	2.49
cerebral meninges, adult	10188-103D8	221.13	102.62	135.15	30.26	44.12	17.40	13.36	3.78	2.52	2.27
cerebrospinal fluid, donor2	10294-104G6	41.66	37.28	33.62	11.69	9.50	2.19	1.46	2.19	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	64.99	30.34	57.80	94.47	5.46	1.87	0.72	1.44	0.00	2.16
cervical cancer cell line:ME-180	10553-107I4	203.50	77.56	103.74	74.90	27.34	5.97	7.13	1.49	5.47	1.16
cervix, adult, pool1	10013-101C4	133.02	96.38	101.53	39.58	33.39	9.66	10.92	5.04	3.46	1.99
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	119.13	196.89	29.96	8.64	22.15	4.18	4.32	1.11	1.11	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	39.19	28.74	32.66	10.45	5.23	0.00	3.92	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	141.55	119.06	70.84	221.21	8.08	2.98	1.74	1.99	1.74	2.36
choriocarcinoma cell line:SCH	10785-110H2	213.90	54.46	91.55	110.89	17.25	6.65	4.07	1.23	36.72	2.96
choriocarcinoma cell line:T3M-3	10618-108G6	43.17	22.77	25.62	84.67	0.95	0.95	0.00	1.42	1.66	0.71
chorionic membrane cells, donor1	12238-129G6	161.83	45.59	72.08	62.40	11.97	2.56	2.28	3.70	9.12	4.56
chorionic membrane cells, donor2	12239-129G7	129.56	135.52	50.11	35.30	17.50	5.47	3.68	2.29	1.89	5.47
chorionic membrane cells, donor3	12240-129G8	124.73	57.15	72.53	114.29	12.09	3.85	1.10	6.59	3.30	4.40
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	101.99	68.67	91.89	170.66	45.44	19.19	12.12	10.10	14.14	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	139.66	91.05	112.57	69.92	19.21	5.57	6.15	8.26	0.19	2.88
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	111.93	69.69	94.40	76.66	11.83	6.12	3.17	22.39	2.53	8.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	58.29	69.34	34.15	100.15	13.35	3.08	1.54	7.45	0.51	3.85
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	57.57	69.90	43.30	89.74	11.13	2.18	2.90	8.95	0.97	4.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	73.71	92.85	41.33	84.70	20.16	2.85	4.68	6.52	2.04	4.89
chronic myelogenous leukemia cell line:K562	10454-106G4	104.53	158.12	57.71	95.99	15.90	2.65	5.30	7.66	0.00	5.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	179.31	233.00	101.12	116.24	27.37	14.07	7.82	18.50	3.91	3.39
clear cell carcinoma cell line:JHOC-5	10638-108I8	123.43	51.66	175.09	96.92	55.55	9.60	9.60	4.34	3.66	5.26
clear cell carcinoma cell line:TEN	10636-108I6	157.02	122.15	90.57	70.79	27.07	3.30	7.29	3.82	1.91	5.90
colon carcinoma cell line:CACO-2	10513-107D9	91.89	56.74	66.44	78.71	14.09	4.58	3.84	1.65	2.93	12.81
colon carcinoma cell line:COLO-320	10420-106C6	22.80	25.85	30.03	219.69	11.40	6.08	1.90	0.76	0.00	1.14
colon, adult, donor1	10082-102B1	54.74	28.56	21.42	99.96	4.76	3.57	1.19	0.00	5.95	0.00
colon, adult, pool1	10014-101C5	73.32	103.05	29.49	119.15	8.58	5.52	3.06	4.82	2.00	2.23
colon, fetal, donor1	10070-101I7	66.74	37.70	50.06	108.15	17.92	7.42	3.71	3.71	3.71	3.71
common myeloid progenitor CMP, donor1	12130-128D6	215.43	206.26	77.92	9.17	13.75	9.17	18.33	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	75.11	75.11	25.04	50.07	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	118.56	265.58	41.22	58.22	48.02	5.10	11.05	6.37	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	80.45	248.58	34.26	59.92	63.09	6.64	8.00	9.81	1.21	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	137.06	227.87	55.98	65.85	65.85	6.91	10.43	11.84	0.56	2.26
corpus callosum, adult, pool1	10042-101F6	154.46	85.24	79.72	14.48	27.53	3.65	7.74	2.87	1.44	1.66
cruciate ligament, donor2	10295-104G7	78.62	78.62	55.11	12.97	9.73	4.05	4.05	2.43	2.43	0.81
diaphragm, fetal, donor1	10069-101I6	40.93	13.64	36.92	9.63	7.22	3.21	0.80	0.80	1.61	2.41
diencephalon, adult	10193-103E4	123.11	71.04	98.40	15.60	26.64	4.56	5.28	1.44	2.16	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	51.89	49.37	28.24	53.27	5.97	2.76	2.07	7.35	0.46	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	416.20	134.12	307.73	149.76	36.41	7.95	5.13	3.85	4.87	5.64
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	108.81	97.01	49.83	10.35	33.22	5.54	6.02	0.24	22.87	3.37
ductus deferens, adult	10196-103E7	42.36	38.37	30.90	44.35	7.97	7.48	3.49	4.49	4.98	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	28.80	31.69	73.45	8.64	8.64	1.44	4.32	2.88	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	68.42	60.32	59.59	88.28	22.07	7.36	3.68	2.94	3.68	1.47
dura mater, adult, donor1	10041-101F5	78.95	120.16	52.77	33.70	21.64	8.18	7.19	5.78	1.57	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	63.29	82.83	19.76	28.20	11.10	6.00	2.89	1.33	4.66	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	183.85	211.93	85.26	39.12	28.23	15.48	7.45	2.15	4.59	4.01
embryonic pancreas cell line:1B2C6	10604-108F1	93.11	31.45	52.41	52.41	6.78	3.08	0.00	1.23	1.23	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	118.36	45.10	89.91	61.15	25.43	3.94	4.24	1.51	0.00	1.82
embryonic pancreas cell line:1C3IKEI	10606-108F3	113.62	56.50	64.84	58.66	20.07	3.09	3.09	2.16	2.16	1.85
embryonic pancreas cell line:2C6	10603-108E9	93.26	63.05	49.91	47.28	14.45	0.00	2.63	6.57	0.00	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	113.97	63.69	82.12	58.99	16.76	4.69	4.02	1.34	2.68	10.73
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	110.19	51.29	126.14	67.42	45.67	3.44	6.52	2.90	1.09	3.44
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	147.63	104.21	101.79	54.03	29.75	8.52	6.59	1.77	27.50	3.86
epidermoid carcinoma cell line:A431	10426-106D3	397.73	194.08	194.08	115.72	31.79	11.23	8.34	4.56	4.78	3.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	534.31	217.44	231.30	130.88	48.28	11.77	8.80	6.49	7.15	3.85
epididymis, adult	10197-103E8	47.93	41.23	37.05	30.14	16.12	8.58	3.14	3.77	3.35	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	78.59	60.14	85.51	29.45	39.56	11.00	8.34	3.19	1.95	6.56
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	93.59	87.30	48.37	35.39	26.74	7.86	7.08	0.79	3.93	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	139.83	55.04	84.26	46.65	9.96	3.54	4.19	1.83	5.90	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	133.36	46.85	65.55	50.10	7.87	4.82	3.84	1.18	3.54	2.17
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	160.31	48.96	88.06	43.13	12.21	4.59	3.92	0.78	6.39	2.24
esophagus, adult, pool1	10015-101C6	198.02	128.69	99.70	70.61	21.55	11.36	6.37	5.42	7.01	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	90.04	72.14	99.06	30.43	59.49	25.05	15.28	1.25	7.51	4.38
eye - muscle inferior rectus, donor1	10272-104E2	7.24	12.07	14.49	0.00	4.83	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	35.77	25.25	33.67	8.42	4.21	2.10	0.00	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	7.44	5.95	4.46	1.49	2.98	1.49	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	30.96	29.81	27.52	10.32	5.73	3.44	0.00	5.73	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	69.95	45.18	45.18	24.78	17.49	2.91	1.46	4.37	1.46	1.46
eye, fetal, donor1	10054-101G9	95.08	30.51	70.42	33.05	23.90	6.36	8.39	3.81	1.02	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	83.73	48.08	48.85	23.21	10.00	2.05	2.82	1.92	0.77	1.67
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	98.05	63.63	50.33	19.47	17.81	4.04	4.27	3.09	2.61	3.09
frontal lobe, adult, pool1	10040-101F4	299.67	279.31	200.60	42.03	86.22	15.29	29.37	5.25	4.03	3.10
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	145.02	76.86	77.76	83.77	23.72	6.31	6.91	2.70	5.70	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	259.31	131.30	138.98	74.06	63.46	16.09	10.33	3.20	2.10	5.94
gall bladder, adult	10198-103E9	72.67	46.11	40.32	48.05	11.59	7.48	4.10	5.31	4.35	1.93
gamma delta positive T cells, donor1	11937-126A2	195.42	204.00	134.21	238.36	10.74	1.07	4.83	34.90	0.00	4.29
gamma delta positive T cells, donor2	11938-126A3	207.66	228.58	138.57	165.08	19.42	2.61	4.11	33.99	2.24	2.99
gastric adenocarcinoma cell line:MKN1	10614-108G2	111.31	72.87	41.61	25.13	12.25	6.34	1.69	1.90	7.60	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	83.36	49.13	52.22	41.58	7.16	4.26	3.09	0.39	7.93	3.87
gastric cancer cell line:AZ521	10549-107H9	100.34	74.76	107.55	85.42	57.06	7.38	9.02	0.82	2.13	3.77
gastric cancer cell line:GSS	10560-108A2	42.10	30.20	73.22	44.85	16.47	0.92	2.75	0.92	0.00	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	106.00	76.30	52.55	37.92	34.04	12.79	11.19	2.74	8.68	3.20
giant cell carcinoma cell line:LU65	10487-107B1	106.13	65.52	46.93	65.06	3.33	0.57	0.57	0.69	0.11	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	276.42	164.87	219.74	77.82	50.53	15.12	12.88	5.04	4.06	8.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	117.23	40.16	68.09	96.77	7.73	2.24	4.24	1.75	5.74	3.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	183.03	110.51	67.55	27.34	42.75	13.41	11.82	1.69	11.82	2.85
glioblastoma cell line:A172, tech_rep2	10444-106F3	150.69	108.70	69.38	23.73	42.27	9.27	13.20	1.83	10.67	3.93
glioblastoma cell line:T98G	10485-107A8	182.78	229.13	68.32	12.25	86.75	19.98	21.96	4.30	8.28	11.15
glioma cell line:GI-1	10413-106B8	186.56	263.00	75.56	67.07	44.81	14.64	10.25	3.81	1.76	5.86
globus pallidus - adult, donor10196	10175-103C4	67.79	40.09	52.48	8.75	12.39	3.64	5.10	0.00	1.46	2.92
globus pallidus, adult, donor10252	10161-103A8	96.66	39.06	53.46	15.87	13.67	2.69	5.37	2.69	2.20	2.44
globus pallidus, adult, donor10258	10367-105F7	58.88	43.81	42.45	5.48	21.91	6.85	5.48	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	90.06	30.91	44.77	10.66	13.86	1.07	5.86	0.53	3.20	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	230.03	139.49	80.76	17.13	2.45	2.45	9.79	2.45	4.89	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	54.64	98.36	65.57	32.79	0.00	10.93	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	41.81	26.13	41.81	10.45	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	72.00	49.60	43.84	11.52	16.64	8.32	5.44	1.60	3.20	1.92
hIPS +CCl2, biol_rep1	14383-156B9	52.80	76.21	57.39	22.96	39.48	19.28	8.26	3.21	7.80	5.05
hIPS +CCl2, biol_rep2	14384-156C1	44.35	62.64	65.85	15.09	42.53	13.26	7.32	3.20	4.12	2.29
hIPS +CCl2, biol_rep3	14385-156C2	32.85	39.29	45.73	21.26	45.09	7.73	7.73	1.93	5.80	3.86
hIPS, biol_rep1	14380-156B6	63.24	47.43	76.18	5.75	38.81	12.94	0.00	1.44	15.81	0.00
hIPS, biol_rep2	14381-156B7	34.29	36.35	44.58	15.09	26.75	13.03	4.80	2.74	9.60	7.54
hIPS, biol_rep3	14382-156B8	62.90	96.00	66.21	23.17	32.00	8.83	3.31	2.21	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	75.00	63.50	38.50	117.24	17.53	4.60	3.74	6.90	2.30	2.01
heart - mitral valve, adult	10205-103F7	57.10	44.55	36.18	5.68	13.75	4.48	3.59	4.78	2.99	1.20
heart - pulmonic valve, adult	10206-103F8	55.96	46.02	37.39	7.06	9.67	7.32	8.89	3.66	5.75	0.78
heart - tricuspid valve, adult	10207-103F9	36.64	13.32	33.31	6.66	5.00	1.67	0.83	1.67	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	180.59	94.27	121.01	75.30	80.40	24.49	20.41	3.26	43.46	8.98
heart, adult, diseased, donor1	10051-101G6	32.36	35.34	20.44	5.96	3.83	7.66	2.13	2.13	1.28	0.00
heart, adult, pool1	10016-101C7	59.33	26.22	28.98	14.72	5.75	2.76	2.53	2.30	3.45	0.23
heart, fetal, pool1	10046-101G1	134.72	89.64	59.45	23.10	29.16	17.76	12.22	6.16	4.00	1.95
hepatic mesenchymal tumor cell line:LI90	10778-110G4	108.29	68.49	31.16	2.16	5.24	3.09	3.70	4.63	1.23	3.70
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	24.97	21.41	47.57	2.38	2.38	1.19	0.00	5.95	10.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	62.98	41.88	39.78	73.70	10.50	2.76	1.33	0.55	3.09	4.75
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	73.19	49.04	45.39	78.04	11.41	4.37	3.03	1.21	2.79	4.25
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.11	51.84	46.48	84.99	10.00	3.44	3.23	1.11	1.72	5.25
hepatoma cell line:Li-7	10484-107A7	123.56	125.01	37.59	66.28	19.91	4.34	3.67	1.00	1.45	3.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	84.02	79.40	29.85	108.64	7.64	5.43	1.91	3.52	1.51	2.21
hippocampus - adult, donor10196	10169-103B7	158.98	111.67	124.92	4.73	35.01	15.14	11.36	3.79	11.36	1.89
hippocampus, adult, donor10252	10153-102I9	154.10	61.64	93.07	11.23	30.61	7.55	10.20	2.04	4.69	2.04
hippocampus, adult, donor10258	10374-105G5	109.55	130.96	65.73	10.46	35.85	13.44	9.96	1.99	2.99	1.49
hippocampus, newborn, donor10223	10363-105F3	143.11	71.91	84.24	7.75	34.54	6.70	11.28	0.70	3.52	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	115.97	145.26	63.48	100.71	72.63	30.52	7.93	7.93	8.54	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	69.51	70.69	58.51	52.62	46.93	11.19	8.25	3.14	5.50	2.36
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	84.80	81.25	52.05	64.49	52.81	13.20	9.65	4.06	6.86	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	34.96	69.36	34.40	35.52	90.22	18.04	14.66	0.56	10.71	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	42.35	82.11	55.26	20.66	113.35	22.98	16.53	2.07	8.26	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	54.66	100.98	42.14	26.95	135.14	18.60	24.30	1.14	5.31	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	62.48	74.45	42.04	32.41	101.89	27.74	25.11	1.75	28.03	6.13
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	65.49	77.34	56.87	27.36	101.25	24.13	27.79	2.15	25.42	7.11
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	59.64	77.16	29.20	25.02	95.93	18.35	25.44	2.50	20.85	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	152.73	123.37	67.72	42.86	145.86	23.68	35.99	1.66	15.63	3.79
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	94.66	83.41	55.77	28.13	124.40	27.32	28.77	1.45	22.98	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	133.31	113.11	70.70	35.01	127.25	23.57	24.91	1.35	10.10	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	66.66	76.05	39.28	48.98	45.54	7.98	5.63	2.97	5.79	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	58.96	83.52	33.41	41.76	39.79	13.26	8.84	2.95	5.40	3.93
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	82.04	158.84	48.00	73.31	79.42	13.96	9.60	2.62	3.49	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.59	108.82	43.91	29.97	118.17	18.33	18.90	2.10	6.87	6.30
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	49.71	86.34	35.76	29.22	100.30	22.24	20.93	0.87	11.34	5.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	34.48	109.45	25.99	33.98	111.95	16.49	18.49	2.00	10.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	37.11	68.76	49.17	33.16	87.23	11.68	14.69	0.75	7.35	8.10
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.47	61.39	53.20	22.28	90.49	22.28	14.10	0.91	7.28	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	30.70	51.68	33.20	24.43	77.68	18.79	18.79	0.94	5.33	5.64
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	61.56	96.35	38.21	38.38	83.45	17.80	21.23	1.14	16.17	3.43
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	51.09	85.35	33.68	32.51	77.51	19.45	19.74	0.87	16.26	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	43.94	64.27	30.49	31.39	73.54	18.83	19.73	0.60	15.25	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	74.82	89.23	53.21	47.48	54.13	17.55	10.53	1.85	8.13	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	57.06	75.89	39.08	45.36	53.35	14.26	6.56	3.14	13.12	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	114.74	115.96	60.84	64.92	77.17	20.82	12.66	4.90	13.07	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.25	89.43	33.45	27.46	85.91	29.57	15.49	0.70	16.55	7.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.29	73.48	25.34	26.92	82.99	22.81	17.42	2.22	12.04	5.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	36.62	93.51	28.14	30.87	78.08	28.14	22.39	1.82	11.50	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	31.54	45.51	31.54	28.44	69.81	21.20	18.10	2.59	11.38	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	35.86	57.12	29.22	23.91	64.42	21.25	15.94	1.33	7.97	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.33	61.57	37.97	26.42	69.78	26.17	18.21	1.28	8.72	4.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.01	85.39	30.68	29.14	72.09	25.31	17.90	1.53	16.36	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	57.55	68.91	37.86	27.26	73.45	31.80	26.50	1.51	18.17	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	59.82	84.01	36.97	35.62	81.33	23.19	22.52	0.34	21.84	3.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	67.62	72.69	49.51	45.16	64.97	17.39	9.42	3.14	11.35	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	69.52	99.38	54.37	46.79	65.07	15.60	12.92	3.57	8.91	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	67.32	89.27	37.07	46.83	68.78	18.05	8.29	3.90	8.78	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	41.87	76.10	37.90	20.17	90.77	28.73	18.64	0.31	10.09	3.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	237.49	891.39	169.17	104.10	696.19	253.75	243.99	16.27	29.28	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	66.85	134.69	50.63	35.08	140.98	35.74	19.53	3.97	11.58	7.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	48.71	65.68	56.92	19.70	95.23	25.72	24.63	2.19	22.99	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.04	61.52	39.81	29.31	79.98	30.76	23.16	0.72	15.92	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	48.75	69.75	38.08	20.64	78.65	30.60	24.56	0.36	17.08	5.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	53.70	79.96	45.35	22.67	93.08	31.03	32.22	1.19	13.13	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	139.76	160.07	65.14	31.69	129.87	45.50	37.11	1.76	27.90	5.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	80.28	88.90	34.48	26.13	83.51	32.06	24.25	0.27	25.59	1.35
immature langerhans cells, donor1	11904-125F5	187.91	185.97	72.40	104.61	18.40	7.51	5.57	8.96	2.66	1.70
immature langerhans cells, donor2	11905-125F6	137.04	64.95	76.84	89.51	15.84	3.17	2.38	2.38	19.01	3.96
insula, adult, pool1	10039-101F3	352.04	282.76	239.33	37.57	104.66	14.48	30.47	3.12	5.20	3.41
keratoacanthoma cell line:HKA-1	10791-110H8	96.24	30.56	71.21	75.11	12.68	2.28	2.93	1.30	7.80	4.88
kidney, adult, pool1	10017-101C8	85.81	71.69	48.36	67.59	21.83	6.71	4.81	4.61	3.70	3.20
kidney, fetal, pool1	10045-101F9	86.65	45.62	60.05	66.28	28.51	4.81	5.38	2.55	2.97	2.69
large cell lung carcinoma cell line:IA-LM	10509-107D5	170.28	128.95	103.39	40.90	54.11	13.78	11.93	6.25	4.97	14.34
large cell lung carcinoma cell line:NCI-H460	10839-111E2	44.38	30.27	15.62	38.43	5.67	1.24	1.11	1.24	0.28	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	154.32	29.18	83.68	54.68	26.97	3.49	6.61	2.02	2.20	2.75
left atrium, adult, donor1	10079-102A7	23.97	31.60	15.80	7.63	3.81	6.54	1.63	0.54	1.09	1.63
left ventricle, adult, donor1	10078-102A6	33.37	18.20	13.15	10.11	6.07	4.05	4.05	2.53	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	107.80	58.55	51.71	9.58	25.45	9.58	7.93	0.82	6.84	1.64
leiomyoma cell line:10964C	10569-108B2	95.56	81.91	47.06	3.23	9.70	3.23	2.51	1.44	2.87	2.51
leiomyoma cell line:15242A	10570-108B3	76.09	89.13	33.15	6.52	11.96	3.80	2.17	2.17	4.89	3.26
leiomyoma cell line:15425	10571-108B4	118.01	111.45	57.06	6.56	19.18	7.53	5.34	2.43	2.19	4.13
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	63.49	19.05	6.35	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	74.23	67.96	19.87	13.59	17.77	23.00	9.41	2.09	12.55	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	175.32	168.94	59.86	48.05	14.99	6.97	5.55	6.61	2.48	3.07
liposarcoma cell line:KMLS-1	10782-110G8	71.23	76.39	27.02	7.97	7.34	3.12	2.03	2.19	0.31	4.22
liposarcoma cell line:SW 872	10726-110A6	167.16	77.25	55.44	15.11	42.89	11.94	11.70	2.68	13.16	7.92
liver, adult, pool1	10018-101C9	44.57	46.19	22.85	56.24	6.32	2.27	1.13	2.59	0.65	0.65
liver, fetal, pool1	10086-102B5	19.75	12.23	17.87	22.58	4.70	5.64	4.70	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	94.35	50.75	60.37	22.02	13.27	3.50	3.65	0.29	1.75	1.17
locus coeruleus, adult, donor10252	10165-103B3	125.86	57.95	71.97	18.64	15.13	3.32	4.06	2.40	2.95	2.77
locus coeruleus, adult, donor10258	10375-105G6	61.51	45.42	40.91	16.08	14.11	6.77	6.77	1.41	1.41	2.54
locus coeruleus, newborn, donor10223	10362-105F2	87.07	83.70	63.09	23.13	24.82	5.89	5.05	2.94	2.10	0.00
lung adenocarcinoma cell line:A549	10499-107C4	102.41	51.07	59.79	109.33	15.22	3.18	1.80	0.97	2.35	1.25
lung adenocarcinoma cell line:PC-14	10408-106B3	98.59	45.50	75.83	48.26	22.75	9.65	5.52	2.07	9.65	9.65
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	190.21	47.19	133.93	88.98	33.09	15.29	10.02	3.30	10.94	12.26
lung, adult, pool1	10019-101D1	88.24	82.22	51.98	74.42	15.36	3.43	3.54	6.14	1.89	1.89
lung, fetal, donor1	10068-101I5	98.18	93.61	77.35	53.37	34.53	4.28	4.85	13.41	2.57	4.00
lung, right lower lobe, adult, donor1	10075-102A3	33.91	31.62	24.74	44.91	12.83	5.04	3.21	6.42	2.75	1.83
lymph node, adult, donor1	10077-102A5	65.32	50.18	38.82	78.10	8.99	2.37	1.42	4.73	0.47	2.84
lymphangiectasia cell line:DS-1	10727-110A7	85.70	67.07	32.66	50.41	2.19	2.85	0.66	2.41	1.53	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	85.88	62.79	80.59	153.49	11.17	4.38	1.96	7.85	0.91	3.02
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	436.64	151.21	294.77	104.49	27.18	4.25	11.89	4.25	17.84	6.80
mature adipocyte, donor1	12231-129F8	220.66	116.33	75.03	15.10	14.65	3.55	4.44	1.33	7.99	16.43
mature adipocyte, donor2	12232-129F9	202.96	120.37	74.50	11.21	9.34	2.49	3.32	2.49	1.66	11.83
mature adipocyte, donor3	12233-129G1	217.15	141.76	73.49	11.38	11.62	2.13	4.03	1.66	3.79	9.96
mature adipocyte, donor4	12234-129G2	295.86	168.99	91.60	17.90	22.37	4.47	3.42	1.32	4.47	13.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	153.92	103.17	113.41	148.44	26.92	5.48	4.05	3.81	2.62	6.91
medial frontal gyrus - adult, donor10196	10170-103B8	150.03	137.62	124.08	23.69	48.51	14.66	15.79	3.38	4.51	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	163.68	91.95	94.90	22.62	22.07	4.97	8.83	1.10	2.02	2.94
medial frontal gyrus, adult, donor10258	10368-105F8	76.88	101.66	70.21	27.32	35.58	10.17	6.99	1.27	2.22	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	350.15	336.07	244.38	20.47	152.26	26.87	54.59	4.26	12.79	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	224.10	170.61	145.97	32.91	71.21	24.81	18.39	2.70	3.88	2.03
medial temporal gyrus, adult, donor10252	10156-103A3	165.75	87.44	97.41	20.80	22.92	6.79	10.40	0.64	2.33	3.18
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	102.09	144.47	86.68	11.56	55.86	5.78	5.78	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	516.73	976.05	373.19	200.95	358.84	100.48	28.71	43.06	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	169.42	114.14	130.65	7.90	86.86	12.56	21.18	0.00	12.92	1.44
medulla oblongata - adult, donor10196	10174-103C3	38.94	33.75	31.15	14.28	20.77	5.84	1.95	2.60	3.24	1.30
medulla oblongata, adult, donor10252	10155-103A2	96.29	48.30	63.16	21.05	16.87	2.79	4.64	2.48	2.17	2.01
medulla oblongata, adult, pool1	10038-101F2	146.68	113.30	93.06	35.59	28.24	4.90	10.29	3.75	1.63	2.86
medulla oblongata, newborn, donor10223	10361-105F1	72.91	35.76	47.91	13.54	12.85	2.78	3.12	0.00	2.78	0.35
medulloblastoma cell line:D283 Med	10838-111E1	177.79	97.64	156.10	40.30	168.27	32.77	26.79	6.20	7.53	6.86
medulloblastoma cell line:ONS-76	10759-110E3	193.44	88.53	98.31	33.50	20.66	6.11	6.85	3.06	5.14	5.62
melanoma cell line:COLO 679	10514-107E1	153.81	94.44	81.65	29.04	48.16	3.59	7.91	3.16	3.02	6.47
melanoma cell line:G-361	10465-106H6	138.72	149.03	64.07	35.56	29.32	5.70	4.89	2.71	1.63	4.61
meningioma cell line:HKBMM	10691-109F7	181.99	67.30	76.52	20.26	24.06	7.24	5.61	6.51	3.98	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	103.10	74.02	86.35	140.10	75.78	15.86	10.57	0.88	0.88	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	203.75	92.02	171.61	118.98	87.36	17.11	17.89	2.59	13.22	11.41
mesenchymal precursor cell - adipose, donor1	11747-123G1	93.13	143.77	50.94	5.06	28.54	4.60	5.06	3.53	0.77	4.14
mesenchymal precursor cell - adipose, donor2	11748-123G2	65.62	88.16	29.81	2.91	17.09	3.45	2.73	2.18	0.73	2.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	63.77	60.46	30.64	1.24	21.95	2.48	2.90	2.90	5.38	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	44.67	84.71	24.72	3.65	7.30	2.53	2.11	1.40	0.56	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.05	67.59	19.83	2.89	10.01	4.62	2.70	2.31	0.39	1.73
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	29.15	64.55	27.07	5.55	13.19	5.55	2.08	2.08	0.00	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	50.63	66.59	21.97	8.75	5.15	2.57	2.06	2.06	0.51	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	61.07	74.65	35.65	4.03	14.26	3.68	4.03	2.76	3.57	1.50
mesenchymal precursor cell - cardiac, donor3	11754-123G8	73.08	119.64	37.93	4.11	23.74	7.30	4.38	2.92	1.86	2.39
mesenchymal precursor cell - cardiac, donor4	11755-123G9	89.67	98.31	57.80	6.35	21.88	4.73	4.46	4.05	2.30	2.84
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	88.20	140.27	44.53	9.53	20.91	3.70	3.98	4.84	2.99	3.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.80	57.64	29.64	4.28	13.83	4.61	4.28	3.29	2.31	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	73.89	110.97	38.61	7.06	22.55	5.81	5.26	4.15	1.80	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	83.78	96.00	56.90	6.28	13.27	3.49	3.84	1.75	0.35	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	65.95	99.22	34.10	2.86	16.33	3.88	2.65	3.67	1.02	2.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	49.96	79.44	32.35	4.67	33.07	3.95	8.99	1.08	3.95	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	59.17	85.35	30.31	10.76	10.14	2.90	2.59	3.21	1.66	1.66
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	75.47	108.30	33.06	5.24	20.06	5.02	6.84	1.60	11.86	3.42
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	138.87	164.89	94.82	10.91	34.82	5.87	7.13	8.39	3.78	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	53.05	93.85	30.04	2.54	11.21	3.44	2.84	4.18	0.60	2.69
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	82.02	122.11	36.68	17.77	20.57	4.38	3.59	2.80	4.29	2.19
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	63.32	77.68	37.18	4.42	12.52	2.58	4.79	2.58	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.66	90.43	31.48	3.15	31.19	5.15	6.58	4.29	3.15	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	116.62	93.47	85.89	5.47	25.26	3.37	5.89	3.37	1.26	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.93	63.48	28.77	1.83	9.13	2.28	3.65	3.20	0.91	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	48.60	78.78	35.55	4.09	14.84	4.09	3.33	3.33	0.51	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	60.73	65.44	35.60	4.71	17.01	3.40	5.24	3.93	0.79	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	58.84	69.94	40.36	5.24	11.09	2.46	3.70	2.77	0.62	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	46.84	80.49	37.66	4.00	15.30	4.24	2.82	2.35	0.47	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	43.66	68.37	40.28	2.71	12.86	2.03	3.05	3.38	1.69	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	54.62	71.13	37.33	3.93	9.43	2.36	3.54	1.96	0.39	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	47.73	60.24	26.88	6.02	13.44	1.85	1.85	1.39	0.00	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	48.30	0.00	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.87	89.70	44.42	4.90	17.31	4.90	3.75	4.04	0.58	4.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	56.00	69.83	37.70	4.91	11.38	4.24	3.35	2.68	0.89	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	53.84	74.51	43.74	4.81	14.18	2.64	4.33	2.88	0.48	1.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.13	89.47	42.53	5.13	16.87	6.60	4.40	2.20	0.73	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	42.63	64.45	37.59	6.04	10.41	3.02	2.69	2.01	0.67	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	46.67	70.82	44.62	5.32	12.28	1.64	3.68	0.41	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.67	62.29	38.23	1.72	12.46	3.44	3.01	3.01	1.29	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	65.63	27.34	2.73	13.67	2.73	2.73	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	36.15	15.49	5.16	10.33	0.00	10.33	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	46.12	60.41	40.27	6.17	14.29	2.92	2.92	0.97	0.65	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	59.65	43.65	4.36	14.55	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	58.64	67.70	41.58	5.33	12.79	4.26	2.13	0.53	1.07	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	51.52	55.61	28.62	5.72	9.00	0.82	3.27	1.64	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	62.20	56.36	38.48	4.66	12.05	2.33	2.72	2.33	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	62.96	44.07	37.78	6.30	8.39	10.49	4.20	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	45.70	56.63	17.88	2.98	17.88	4.97	5.96	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	76.28	38.14	33.37	4.77	9.53	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	47.44	61.67	37.36	3.56	14.82	2.96	1.19	2.37	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	42.65	84.07	40.21	2.44	8.53	6.09	3.66	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	27.05	0.00	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	56.37	72.21	31.04	3.80	12.67	3.17	4.43	3.17	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.63	37.94	16.90	4.83	5.52	2.41	1.03	1.03	1.03	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	49.43	27.94	4.30	4.30	4.30	2.15	2.15	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	35.93	7.98	3.99	0.00	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	37.88	3.44	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.86	22.82	11.00	2.85	2.04	1.22	0.41	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.98	20.66	11.12	2.38	6.36	1.59	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.17	19.45	12.38	2.36	4.72	0.59	0.00	0.00	0.00	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.13	18.70	11.53	1.25	2.49	0.62	0.94	0.94	0.00	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	16.04	13.37	2.67	4.01	1.34	1.34	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	26.02	30.75	1.18	13.01	0.00	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	53.93	15.41	2.57	7.70	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	47.50	29.60	19.28	2.07	10.33	0.69	1.38	0.69	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	82.14	62.84	38.10	2.97	13.36	2.47	0.00	0.00	8.91	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	51.59	48.22	37.01	1.12	8.97	3.36	1.12	0.00	5.61	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	71.24	66.79	41.34	5.09	10.18	0.00	1.91	0.00	8.90	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	50.78	49.97	32.24	3.22	6.45	1.61	0.00	1.21	4.03	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	98.13	47.97	23.99	2.18	6.54	0.00	2.18	0.00	2.18	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	50.68	51.95	17.74	1.27	3.80	2.53	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	22.45	14.57	7.28	3.03	0.00	0.61	1.21	1.21	4.86
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	13.56	13.56	18.08	4.52	0.00	0.00	0.00	4.52	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.01	24.71	12.36	9.06	1.65	0.00	0.82	0.00	0.82	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	63.30	51.79	27.38	1.39	10.52	1.98	2.78	0.60	1.98	1.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	53.87	45.10	30.18	1.62	5.52	0.97	1.30	0.65	3.89	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	43.80	43.80	20.37	2.04	5.09	1.02	1.02	0.00	3.06	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	120.70	49.52	54.16	3.09	11.61	2.32	4.64	1.55	1.55	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	250.18	158.52	200.33	58.12	37.80	5.67	6.85	1.18	2.83	3.31
mesothelioma cell line:ACC-MESO-4	10494-107B8	94.06	96.38	55.37	52.82	41.24	9.27	9.73	2.09	20.39	5.79
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	132.48	123.93	81.20	12.82	42.74	8.55	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	136.14	118.27	36.78	18.08	23.22	7.50	7.40	1.03	2.88	2.67
mesothelioma cell line:Mero-25	10850-111F4	83.75	33.14	48.34	22.47	14.98	6.81	3.86	1.13	2.27	2.95
mesothelioma cell line:Mero-41	10851-111F5	163.80	107.57	88.99	16.38	21.51	6.60	6.85	2.44	2.69	2.20
mesothelioma cell line:Mero-48a	10852-111F6	160.32	81.04	87.24	42.74	23.25	9.30	5.76	2.66	2.88	2.66
mesothelioma cell line:Mero-82	10853-111F7	225.49	137.71	85.94	40.73	41.52	11.56	8.41	4.99	9.72	5.26
mesothelioma cell line:Mero-83	10854-111F8	148.77	94.64	50.56	22.30	21.45	12.60	11.58	1.70	11.92	1.19
mesothelioma cell line:Mero-84	10855-111F9	116.28	59.40	65.72	18.20	19.21	5.81	6.57	0.76	5.31	1.77
mesothelioma cell line:Mero-95	10856-111G1	133.54	93.38	66.87	62.53	27.54	6.63	8.49	3.73	5.59	2.90
mesothelioma cell line:NCI-H2052	10847-111F1	216.50	132.35	128.54	15.74	46.71	9.28	13.91	10.60	9.77	6.46
mesothelioma cell line:NCI-H226	10846-111E9	134.66	76.38	61.36	25.70	27.51	10.86	5.25	3.62	6.33	4.16
mesothelioma cell line:NCI-H2452	10848-111F2	71.92	65.60	40.83	20.50	19.30	10.93	6.83	2.05	9.57	3.59
mesothelioma cell line:NCI-H28	10845-111E8	69.98	51.40	36.90	57.51	16.79	5.34	4.07	0.76	1.27	2.80
mesothelioma cell line:No36	10857-111G2	74.70	32.29	36.86	10.11	19.25	7.50	4.89	1.63	1.63	1.63
mesothelioma cell line:ONE58	10858-111G3	95.10	57.98	39.56	8.94	6.77	2.17	2.71	0.81	1.63	1.08
migratory langerhans cells, donor1	11901-125F2	212.65	337.02	92.89	156.99	34.16	11.52	9.21	14.59	0.38	5.37
migratory langerhans cells, donor2	11902-125F3	163.27	141.04	80.23	97.94	15.14	3.30	2.32	10.26	1.10	3.66
migratory langerhans cells, donor3	11903-125F4	157.05	195.99	78.43	168.35	17.95	7.18	3.05	15.44	0.90	2.87
mixed mullerian tumor cell line:HTMMT	10689-109F5	252.69	114.59	95.01	26.12	31.34	16.65	10.77	1.31	2.29	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	112.33	63.79	63.58	4.45	27.13	14.84	6.36	1.70	5.72	3.18
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	310.98	44.69	102.28	77.17	11.98	3.23	4.61	3.46	3.69	3.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	97.62	100.66	29.88	78.59	16.37	3.23	3.23	6.09	1.71	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	113.83	63.01	98.68	220.83	8.13	6.10	3.70	3.51	0.92	1.29
myeloma cell line:PCM6	10474-106I6	67.21	51.99	48.03	119.19	3.95	2.37	1.98	17.39	0.99	10.48
myxofibrosarcoma cell line:MFH-ino	10600-108E6	113.13	38.55	54.79	12.68	26.89	10.65	9.13	0.51	2.54	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	152.60	101.99	83.95	10.40	15.69	6.47	5.49	3.73	2.35	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	212.04	46.69	130.59	123.46	8.91	1.89	1.34	1.67	1.34	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	202.02	56.41	135.24	138.33	10.08	2.79	2.43	1.69	1.10	1.47
nasal epithelial cells, donor2	12227-129F4	157.87	67.89	228.52	65.69	17.11	3.86	4.97	1.10	3.31	1.10
neuroblastoma cell line:CHP-134	10508-107D4	93.40	75.00	95.94	116.18	88.34	4.83	8.05	1.61	1.15	9.66
neuroblastoma cell line:NB-1	10539-107G8	167.44	102.34	179.98	79.14	83.81	11.04	14.97	7.11	0.19	8.04
neuroblastoma cell line:NBsusSR	10607-108F4	48.08	27.84	24.88	22.99	32.69	3.37	2.32	3.59	0.84	2.11
neuroblastoma cell line:NH-12	10555-107I6	78.08	51.81	68.02	37.27	63.17	7.08	7.64	2.98	0.93	2.98
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	67.37	26.33	43.41	39.85	45.07	2.85	4.51	0.95	1.42	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	53.53	55.43	35.32	25.82	83.15	5.70	8.39	1.27	1.90	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	25.56	20.13	19.92	14.09	18.52	4.23	1.61	0.00	0.60	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	70.57	35.60	75.02	19.71	38.78	8.26	5.09	0.64	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	103.27	56.96	44.45	4.26	16.24	3.99	3.73	1.33	2.13	4.52
neutrophil PMN, donor1	12133-128D9	223.12	208.25	104.12	89.25	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	212.49	172.65	13.28	252.33	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	123.12	47.35	56.82	236.77	0.00	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	106.55	96.74	108.74	411.47	26.89	9.47	7.78	12.18	2.20	13.87
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	442.68	263.37	232.15	122.48	63.24	18.41	12.01	2.40	8.81	24.82
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	107.72	56.11	48.73	3.53	22.44	5.13	6.09	0.64	1.92	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	95.91	75.41	46.25	10.51	19.18	7.62	6.04	1.58	1.58	3.15
nucleus accumbens, adult, pool1	10037-101F1	317.87	207.91	208.57	40.68	82.02	11.62	17.15	3.94	3.75	3.00
occipital cortex - adult, donor10196	10172-103C1	117.44	127.74	115.38	28.85	32.97	16.48	18.54	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	106.27	68.16	73.80	17.71	15.83	3.49	6.17	2.15	3.22	0.54
occipital cortex, newborn, donor10223	10355-105E4	240.93	163.05	152.86	11.65	104.82	19.65	25.11	1.09	6.91	0.73
occipital lobe, adult, donor1	10076-102A4	113.36	133.56	89.48	30.18	52.22	18.11	17.84	2.36	3.15	2.89
occipital lobe, fetal, donor1	10073-102A1	184.94	121.44	173.36	64.79	145.04	15.88	27.46	1.72	6.87	3.43
occipital pole, adult, pool1	10036-101E9	189.38	146.25	115.42	40.60	39.26	6.47	11.27	2.92	2.92	1.42
olfactory region, adult	10195-103E6	163.35	104.31	119.79	17.58	39.17	8.98	14.14	2.29	3.44	1.91
optic nerve, donor1	10277-104E7	58.03	32.02	20.01	4.00	10.01	2.00	2.00	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	285.45	160.38	128.49	156.74	15.04	5.35	4.44	3.30	11.16	7.40
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	124.20	99.88	102.35	59.49	46.99	14.70	9.34	3.02	6.73	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	282.94	109.89	144.26	50.12	41.82	8.80	7.79	1.69	8.13	3.73
oral squamous cell carcinoma cell line:SAS	10544-107H4	289.12	181.81	182.04	116.66	41.81	12.13	6.82	12.71	5.20	9.36
osteoclastoma cell line:Hs 706.T	10704-109H2	93.48	80.55	53.80	5.00	8.53	1.76	2.35	2.65	0.59	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	145.76	111.19	48.59	28.03	38.31	4.67	7.47	3.74	0.00	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	275.89	435.15	116.21	55.14	84.19	27.78	20.36	1.91	4.45	4.03
ovary, adult, pool1	10020-101D2	96.26	42.28	85.08	46.03	27.87	7.86	5.85	6.90	0.70	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	127.41	37.21	58.85	9.17	15.95	6.05	4.03	1.83	2.02	2.38
pancreas, adult, donor1	10049-101G4	44.21	15.99	26.34	35.74	1.88	0.94	1.88	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	74.92	42.77	39.97	95.88	12.58	4.47	2.52	1.12	6.15	4.19
papillary adenocarcinoma cell line:8505C	10437-106E5	208.34	111.07	74.44	42.76	30.66	11.92	13.12	5.96	1.19	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	284.30	87.10	139.25	140.41	25.50	6.95	5.80	2.98	10.27	5.30
paracentral gyrus, adult, pool1	10035-101E8	266.24	235.67	178.93	43.56	58.30	9.52	15.74	3.94	2.56	2.56
parietal cortex, adult, donor10258	10373-105G4	101.29	118.18	121.85	19.82	40.37	8.81	5.87	2.20	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	105.33	108.16	74.30	22.57	44.20	7.52	13.17	0.94	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	130.55	86.37	83.23	23.37	23.66	5.42	7.41	1.43	3.99	2.00
parietal lobe, adult, pool1	10034-101E7	266.21	197.21	151.57	39.65	52.61	7.58	15.24	3.35	2.03	1.76
parietal lobe, fetal, donor1	10072-101I9	193.97	152.26	164.87	86.32	158.08	18.43	18.43	2.91	4.85	3.88
parietal lobe, newborn, donor10223	10356-105E5	206.37	146.93	152.53	10.47	92.72	17.20	28.79	0.75	8.60	3.36
parotid gland, adult	10199-103F1	51.18	34.53	41.32	83.25	1.85	1.85	1.85	4.32	0.62	4.93
penis, adult	10200-103F2	57.47	44.58	48.34	18.80	16.65	11.82	5.91	3.22	4.30	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	98.92	63.96	52.99	82.00	63.03	3.72	8.55	1.12	0.56	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	185.62	75.03	122.24	50.99	31.62	9.32	4.52	5.39	6.41	10.34
pineal gland - adult, donor10196	10179-103C8	86.43	35.48	55.47	64.50	16.13	6.45	3.87	5.81	1.94	1.94
pineal gland, adult, donor10252	10160-103A7	148.05	48.56	99.49	140.35	13.03	7.11	4.15	7.70	2.96	2.96
pineal gland, adult, donor10258	10377-105G8	68.98	23.83	58.32	69.61	15.05	4.39	3.76	3.76	0.00	1.88
pituitary gland - adult, donor10196	10180-103C9	48.57	34.40	43.51	57.67	18.21	9.11	7.08	4.05	6.07	0.00
pituitary gland, adult, donor10252	10162-103A9	100.59	60.46	72.97	90.69	16.68	4.17	1.56	3.13	4.17	2.08
pituitary gland, adult, donor10258	10378-105G9	25.54	29.79	53.63	58.74	11.07	2.55	6.81	3.40	0.85	2.55
placenta, adult, pool1	10021-101D3	170.93	83.10	86.86	71.49	13.87	4.95	3.87	3.55	1.40	3.12
plasma cell leukemia cell line:ARH-77	10840-111E3	85.81	93.10	49.79	113.22	11.52	6.36	4.50	10.59	1.32	4.77
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	96.50	58.36	47.00	7.47	20.23	5.91	3.74	2.18	0.78	2.02
pons, adult, pool1	10033-101E6	153.97	217.84	109.13	67.65	21.78	3.53	7.75	5.25	1.29	3.87
postcentral gyrus, adult, pool1	10032-101E5	224.74	196.93	143.23	43.15	56.49	12.73	16.56	3.57	2.35	1.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	41.83	29.28	18.82	0.00	6.27	6.27	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	33.05	55.08	88.13	0.00	5.51	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	58.68	0.00	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	157.31	124.83	126.14	93.95	37.14	14.42	9.91	1.46	7.72	4.66
prostate cancer cell line:PC-3	10439-106E7	291.85	317.26	156.64	129.96	49.55	17.79	15.25	8.17	26.14	11.80
prostate, adult, pool1	10022-101D4	79.99	48.97	52.51	29.02	17.41	10.43	5.89	6.35	3.63	1.45
putamen, adult, donor10196	10176-103C5	380.53	113.07	295.08	32.58	77.43	14.16	13.69	4.96	18.18	1.42
putamen, adult, donor10252	10152-102I8	137.25	58.82	76.47	21.57	13.73	5.88	7.84	0.00	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	104.91	104.91	86.33	17.48	46.99	10.93	1.09	1.09	5.46	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	213.34	94.23	138.20	37.21	56.05	8.70	11.36	2.17	4.11	1.21
putamen, newborn, donor10223	10365-105F5	106.45	151.43	85.46	16.49	57.72	8.25	14.24	3.00	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	114.92	64.01	58.77	189.40	6.40	5.24	1.16	2.62	9.31	3.20
rectum, fetal, donor1	10067-101I4	50.08	36.17	61.20	37.56	40.34	13.91	1.39	2.78	1.39	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	69.75	61.06	47.49	14.20	12.93	4.45	4.03	2.12	2.33	2.97
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	65.03	49.29	42.25	26.51	6.63	1.66	1.24	2.49	0.00	5.80
retina, adult, pool1	10030-101E3	82.70	60.43	57.35	28.43	27.24	9.74	8.65	6.36	3.08	1.69
retinoblastoma cell line:Y79	10475-106I7	160.56	135.10	94.57	124.71	75.08	21.04	15.85	2.08	5.46	6.75
rhabdomyosarcoma cell line:KYM-1	10787-110H4	82.25	49.30	53.73	31.23	32.95	8.24	6.76	1.23	8.61	3.69
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	203.03	95.05	138.63	22.78	129.07	12.65	15.47	1.97	1.41	11.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.96	69.72	30.31	4.55	15.91	8.34	5.30	2.27	0.76	3.03
salivary acinar cells, donor1	11771-123I7	59.24	61.99	33.50	29.46	9.71	3.56	2.10	2.43	1.46	0.81
salivary acinar cells, donor2	11772-123I8	60.72	68.57	39.93	31.53	12.39	4.54	3.58	2.62	2.62	1.93
salivary acinar cells, donor3	11773-123I9	70.18	39.06	29.13	24.50	4.63	2.65	1.32	2.65	5.30	3.97
salivary gland, adult, pool1	10093-102C3	36.03	37.18	21.73	45.18	9.15	0.57	2.29	8.58	0.57	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	114.75	108.93	64.92	71.50	29.17	8.43	6.24	3.29	1.18	1.85
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	99.33	94.39	61.36	62.30	27.04	7.52	5.64	3.76	2.70	2.47
seminal vesicle, adult	10201-103F3	46.03	30.69	30.16	40.21	7.94	7.41	2.12	3.17	1.06	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	140.41	67.29	86.72	30.37	30.37	12.63	7.53	2.67	10.69	4.86
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	123.30	95.12	65.17	15.35	29.44	5.79	4.78	1.76	3.77	3.27
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	153.54	174.61	112.40	15.05	47.17	8.03	11.04	5.02	4.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	85.43	46.21	54.53	17.06	12.89	5.64	4.16	0.67	7.52	5.91
signet ring carcinoma cell line:Kato III	10436-106E4	181.38	83.01	102.68	109.20	9.62	3.76	1.99	3.98	0.77	4.53
signet ring carcinoma cell line:NUGC-4	10483-107A6	90.32	81.93	52.26	103.99	13.55	2.06	2.58	4.26	4.52	2.06
skeletal muscle - soleus muscle, donor1	10282-104F3	14.90	12.06	6.38	3.55	3.55	4.26	2.13	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	40.54	31.66	26.99	13.79	6.60	2.88	1.92	2.88	0.96	0.84
skeletal muscle, fetal, donor1	10066-101I3	38.19	10.05	25.13	11.06	9.05	5.03	4.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	74.64	67.85	47.50	74.64	27.14	0.00	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	41.03	34.09	30.30	39.14	26.51	8.21	6.31	3.16	3.16	5.68
small cell cervical cancer cell line:HCSC-1	10800-110I8	108.39	99.39	77.38	51.70	43.69	5.00	6.00	4.34	15.68	5.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	133.65	57.68	92.67	73.13	93.93	21.75	16.39	0.63	11.35	5.36
small cell lung carcinoma cell line:DMS 144	10841-111E4	63.41	33.92	133.57	64.38	67.85	5.59	10.99	0.58	1.54	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	158.89	131.37	147.36	321.08	27.53	9.89	3.96	17.64	4.62	18.46
small cell lung carcinoma cell line:NCI-H82	10842-111E5	81.71	50.99	75.92	77.53	96.67	6.92	6.27	2.25	1.61	4.83
small cell lung carcinoma cell line:WA-hT	10562-108A4	239.71	139.25	138.16	155.16	66.25	20.92	17.00	8.50	21.57	18.96
small intestine, adult, pool1	10024-101D6	163.76	150.26	59.24	229.69	8.24	4.66	2.99	8.00	2.03	2.63
small intestine, fetal, donor1	10064-101I1	64.62	35.63	49.38	91.89	13.51	5.90	3.44	1.72	0.98	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	113.86	60.52	42.57	49.75	9.75	7.69	1.54	3.08	1.03	3.59
smooth muscle, adult, pool1	10048-101G3	76.50	43.68	48.59	5.43	11.11	22.23	5.94	4.65	2.84	1.29
somatostatinoma cell line:QGP-1	10781-110G7	61.91	20.91	21.44	19.03	1.34	0.54	0.00	1.61	0.27	3.48
spinal cord - adult, donor10196	10181-103D1	63.55	43.13	46.80	16.52	13.76	3.90	2.06	2.06	2.52	2.52
spinal cord, adult, donor10252	10159-103A6	98.17	56.77	55.20	14.98	18.14	5.52	4.73	3.15	1.58	1.97
spinal cord, adult, donor10258	10369-105F9	42.20	44.27	27.67	11.07	19.37	4.15	9.69	2.77	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	65.86	50.62	58.54	17.69	31.10	8.54	8.54	1.83	1.22	1.83
spinal cord, newborn, donor10223	10359-105E8	90.92	64.75	46.38	10.56	12.86	2.30	3.67	2.30	0.92	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	151.30	68.25	51.68	4.78	7.17	3.44	2.84	2.84	1.79	2.84
spleen, adult, pool1	10025-101D7	101.10	96.48	63.44	94.50	8.81	2.86	2.20	11.23	0.55	2.09
spleen, fetal, pool1	10044-101F8	86.92	69.21	52.68	64.52	13.51	2.94	2.54	6.36	0.95	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	78.77	103.51	43.27	69.87	6.94	6.21	2.59	7.45	2.28	3.73
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	178.67	38.92	146.96	65.70	19.18	4.56	3.23	3.61	2.47	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	392.78	240.42	296.68	159.00	188.01	56.96	42.63	4.19	94.70	18.17
squamous cell carcinoma cell line:T3M-5	10616-108G4	168.10	50.43	55.12	30.49	18.37	9.38	3.13	0.39	3.13	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	247.40	178.41	111.10	130.46	20.04	9.45	7.43	4.28	3.04	4.84
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	151.23	49.14	121.57	72.01	58.46	8.05	12.71	1.27	2.54	5.51
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	156.54	36.81	136.65	38.50	38.50	6.77	5.92	1.69	2.54	2.12
stomach, fetal, donor1	10062-101H8	87.57	51.26	44.85	42.72	10.68	16.02	5.34	0.00	7.48	2.14
submaxillary gland, adult	10202-103F4	48.99	32.47	29.62	55.83	3.99	2.28	2.28	6.84	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	108.55	0.00	54.27	0.00	0.00	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	86.20	36.56	45.90	10.18	10.18	2.91	3.12	1.66	1.66	1.04
substantia nigra, adult, donor10258	10371-105G2	47.07	48.10	39.31	16.03	16.55	8.79	3.10	3.62	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	48.05	29.68	33.92	9.89	12.72	2.83	2.12	1.41	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	131.83	118.07	104.32	85.06	65.11	11.00	9.63	3.21	1.83	2.29
temporal lobe, adult, pool1	10031-101E4	258.38	162.34	160.98	25.26	58.15	9.92	13.65	3.39	3.31	1.53
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	178.07	81.20	120.37	70.51	158.12	18.52	27.78	0.71	12.11	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	213.62	118.24	157.35	52.31	145.05	18.02	20.22	2.20	8.79	2.20
tenocyte, donor1	11763-123H8	78.20	60.39	47.13	2.09	13.27	2.44	1.75	1.40	0.00	1.40
tenocyte, donor2	11765-123I1	55.70	52.65	25.18	2.67	16.79	1.14	1.53	1.53	1.53	1.14
tenocyte, donor3	11768-123I4	65.61	63.75	44.11	0.37	7.41	1.85	1.85	3.71	0.74	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	232.34	83.28	126.96	80.56	26.51	11.73	5.95	1.53	11.22	10.54
teratocarcinoma cell line:NCR-G1	10798-110I6	69.06	29.75	41.62	8.94	17.26	8.79	4.16	2.00	4.93	3.24
teratocarcinoma cell line:PA-1	10807-111A6	85.70	51.61	46.34	25.42	35.18	11.93	5.73	4.96	2.17	4.34
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	206.80	116.66	106.26	35.29	50.91	21.83	13.20	3.43	16.12	16.88
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.89	27.61	63.15	29.50	20.42	8.32	3.40	3.78	7.56	5.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	99.57	108.30	83.32	57.91	35.45	6.22	5.34	5.67	8.40	13.74
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	95.76	37.46	96.73	119.86	29.31	4.23	4.56	2.93	4.89	4.23
testis, adult, pool1	10026-101D8	65.93	62.17	56.91	54.22	28.13	7.30	5.48	4.19	1.18	6.98
testis, adult, pool2	10096-102C6	47.82	42.40	62.70	45.56	33.38	4.06	4.96	1.80	2.71	6.77
thalamus - adult, donor10196	10168-103B6	98.25	64.03	66.24	9.94	16.56	4.42	8.83	1.10	2.21	1.10
thalamus, adult, donor10252	10154-103A1	127.53	46.42	69.39	12.35	17.19	3.13	5.31	1.72	1.09	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	87.76	95.46	113.93	4.62	23.09	1.54	6.16	3.08	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	66.37	42.82	44.47	10.05	14.33	3.79	3.29	1.65	1.15	1.65
thalamus, newborn, donor10223	10366-105F6	118.52	101.26	112.19	25.31	25.31	5.75	9.21	0.58	2.88	0.58
throat, adult	10209-103G2	89.63	64.66	49.43	38.20	15.48	3.75	3.99	3.25	6.99	2.00
throat, fetal, donor1	10061-101H7	57.28	24.38	55.46	27.12	21.63	9.45	3.96	1.83	6.70	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	35.77	30.01	49.09	5.76	63.79	3.18	3.97	0.40	0.40	2.58
thymus, adult, pool1	10027-101D9	157.47	122.18	100.51	256.49	27.24	3.78	4.77	7.46	1.09	2.39
thymus, fetal, pool1	10043-101F7	123.75	128.32	62.86	228.17	24.63	5.30	4.26	5.92	1.97	2.60
thyroid carcinoma cell line:KHM-5M	10776-110G2	310.46	286.00	116.47	49.06	73.53	29.52	23.27	3.86	28.72	5.05
thyroid carcinoma cell line:TCO-1	10783-110G9	153.24	78.79	70.26	19.84	32.69	5.59	4.75	2.37	2.24	2.24
thyroid, adult, pool1	10028-101E1	83.70	39.28	73.53	80.62	19.13	5.23	4.11	3.45	3.45	2.15
thyroid, fetal, donor1	10060-101H6	56.69	20.30	57.21	37.97	15.03	5.80	5.27	1.58	9.49	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	15.40	15.40	36.96	9.24	6.16	9.24	6.16	3.08	0.00
tongue, adult	10203-103F5	137.45	85.36	88.61	47.91	23.26	6.98	4.42	2.56	12.33	2.09
tongue, fetal, donor1	10059-101H5	78.03	37.83	60.69	26.80	23.65	3.55	3.94	3.15	8.28	2.36
tonsil, adult, pool1	10047-101G2	169.00	131.03	103.18	165.39	20.64	4.61	4.11	11.32	6.21	2.40
trachea, adult, pool1	10029-101E2	137.50	80.41	83.76	56.36	15.62	7.12	4.34	5.15	3.52	2.94
trachea, fetal, donor1	10058-101H4	66.55	31.16	55.40	22.70	19.62	5.00	4.62	3.08	3.85	3.46
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	97.07	89.63	48.54	2.83	20.90	9.57	6.02	2.48	1.77	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	229.08	143.46	136.47	83.59	41.44	9.93	6.79	5.78	5.27	5.98
transitional-cell carcinoma cell line:JMSU1	10492-107B6	101.38	93.86	92.13	113.60	44.97	8.46	9.87	1.72	1.25	5.48
tridermal teratoma cell line:HGRT	10694-109G1	85.61	53.27	43.76	1.90	9.51	11.42	5.71	5.71	0.00	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	208.58	66.62	90.32	23.19	30.30	9.14	7.11	3.64	23.02	7.20
umbilical cord, fetal, donor1	10057-101H3	77.20	45.90	60.51	29.21	33.38	2.09	16.69	2.09	16.69	4.17
uterus, adult, pool1	10100-102D1	77.64	59.04	59.04	20.65	25.94	9.90	6.14	4.27	1.37	1.19
uterus, fetal, donor1	10055-101H1	92.66	38.91	79.86	23.55	33.79	16.38	9.73	4.61	8.19	3.58
vagina, adult	10204-103F6	54.93	24.56	36.19	29.08	8.40	4.52	3.23	3.23	7.75	0.00
vein, adult	10191-103E2	78.03	42.31	59.18	79.13	11.62	4.16	2.41	5.92	1.53	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	38.19	54.21	16.82	62.49	3.20	3.20	0.80	2.67	1.60	2.14

Property "Nearest transcripts" (as page type) with input value "ENST00000395953.6:114 ENST00000480304.5:-239 BC073141:-245 BC101483:-247 BC111951:-247 ENST00000395956.7:259 BC051814:259 BC063824:-264 AK315867:-279 AK307506:-287 ENST00000521309.5:-289 AK294647:-289 ENST00000395958.6:-290 NM_145690.3:-290 BC013265:-290 BC083508:-292 BC003623:-292 BC072426:-294 BC108281:-302 EU794583:-313 GQ472215:-313 BC068456:-313 U28964:-313 BC099904:-314 EU794582:379 NM_001135701.2:396 NM_001135700.2:396 ENST00000419477.6:432" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.